Regulation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
and	O
p105	B-protein
in	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
persistently	O
infected	O
with	O
human	O
immunodeficiency	O
virus	O
.	O

The	O
mechanisms	O
regulating	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
persistence	O
in	O
human	O
monocytes	B-cell_type
/macrophages	B-cell_type
are	O
partially	O
understood	O
.	O

Persistent	O
HIV	O
infection	O
of	O
U937	B-cell_line
monocytic	I-cell_line
cells	I-cell_line
results	O
in	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

Whether	O
virus-induced	O
NF-kappa	B-protein
B	I-protein
activation	O
is	O
a	O
mechanism	O
that	O
favors	O
continuous	O
viral	O
replication	O
in	O
macrophages	B-cell_type
remains	O
unknown	O
.	O

To	O
further	O
delineate	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
the	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
HIV-infected	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
,	O
we	O
have	O
focused	O
on	O
the	O
regulation	O
of	O
the	O
I	O
kappa	O
B	O
molecules	O
.	O

First	O
,	O
we	O
show	O
that	O
persistent	O
HIV	O
infection	O
results	O
in	O
the	O
activation	O
of	O
NF-kappa	O
B	O
not	O
only	O
in	O
monocytic	O
cells	O
but	O
also	O
in	O
macrophages	B-cell_type
.	O

In	O
HIV-infected	O
cells	O
,	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
protein	O
levels	O
are	O
decreased	O
secondary	O
to	O
enhanced	O
protein	O
degradation	O
.	O

This	O
parallels	O
the	O
increased	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
synthesis	O
secondary	O
to	O
increased	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
gene	O
transcription	O
,	O
i.e.	O
,	O
increased	O
RNA	O
and	O
transcriptional	O
activity	O
of	O
its	O
promoter-enhancer	O
.	O

Another	O
protein	O
with	O
I	O
kappa	O
B	O
function	O
,	O
p105	B-protein
,	O
is	O
also	O
modified	O
in	O
HIV-infected	O
cells	O
:	O
p105	B-protein
and	O
p50	B-protein
steady-state	O
protein	O
levels	O
are	O
increased	O
as	O
a	O
result	O
of	O
increased	O
synthesis	O
and	O
proteolytic	O
processing	O
of	O
p105	B-protein
.	O

Transcriptional	O
activity	O
of	O
p105	B-protein
is	O
also	O
increased	O
in	O
infected	B-cell_type
cells	I-cell_type
and	O
is	O
also	O
mediated	O
by	O
NF-kappa	B-protein
B	I-protein
through	O
a	O
specific	O
kappa	B-DNA
B	I-DNA
motif	I-DNA
.	O

These	O
results	O
demonstrate	O
the	O
existence	O
of	O
a	O
triple	O
autoregulatory	O
loop	O
in	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
involving	O
HIV	O
,	O
p105	B-protein
and	O
p50	B-protein
,	O
and	O
MAD3	B-protein
,	O
with	O
the	O
end	O
result	O
of	O
persistent	O
NF-kappa	O
B	O
activation	O
and	O
viral	O
persistence	O
.	O

Furthermore	O
,	O
persistent	O
HIV	O
infection	O
of	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
provides	O
a	O
useful	O
model	O
with	O
which	O
to	O
study	O
concomitant	O
modifications	O
of	O
different	O
I	B-protein
kappa	I-protein
B	I-protein
molecules	I-protein
.	O

JournaL	NULL
or	NULL
VirRoLoGYy	NULL
,	NULL
Mar	NULL
.	NULL

1995	NULL
,	NULL
p.	NULL
1500-1509	NULL
0022-538	NULL
X/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

69	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Regulation	NULL
of	NULL
IxBa	NULL
and	NULL
p105	NULL
in	NULL
Monocytes	NULL
and	NULL
Macrophages	NULL
Persistently	NULL
Infected	NULL
with	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
JULIE	NULL
A.	NULL
McELHINNY	NULL
,	NULL
'	NULL
WILLIAM	NULL
S.	NULL
MacMORRAN	NULL
,	NULL
``	NULL
GARY	NULL
D.	NULL
BREN	NULL
,	NULL
``	NULL
ROSA	NULL
M.	NULL
TEN	NULL
,	NULL
``	NULL
ALAIN	NULL
ISRAEL	NULL
,	NULL
``	NULL
anp	NULL
CARLOS	NULL
V.	NULL
PAYA'*	NULL
Department	NULL
of	NULL
Immunology	NULL
and	NULL
Division	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
``	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
Minnesota	NULL
55905	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France®	NULL
Received	NULL
18	NULL
July	NULL
1994/Accepted	NULL
29	NULL
November	NULL
1994	NULL
The	NULL
mechanisms	NULL
regulating	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
persistence	NULL
in	NULL
human	NULL
monocytes/macrophages	NULL
are	NULL
partially	NULL
understood	NULL
.	NULL

Persistent	NULL
HIV	NULL
infection	NULL
of	NULL
U937	NULL
monocytic	NULL
cells	NULL
results	NULL
in	NULL
NF-KB	NULL
activation	NULL
.	NULL

Whether	NULL
virus-induced	NULL
NF-KB	NULL
activation	NULL
is	NULL
a	NULL
mechanism	NULL
that	NULL
favors	NULL
continuous	NULL
viral	NULL
replication	NULL
in	NULL
macrophages	NULL
remains	NULL
unknown	NULL
.	NULL

To	NULL
further	NULL
delineate	NULL
the	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
we	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IB	NULL
molecules	NULL
.	NULL

First	NULL
,	NULL
we	NULL
show	NULL
that	NULL
persistent	NULL
HIV	NULL
infection	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-B	NULL
not	NULL
only	NULL
in	NULL
monocytic	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
macrophages	NULL
.	NULL

In	NULL
HIV-infected	NULL
cells	NULL
,	NULL
IxBa	NULL
protein	NULL
levels	NULL
are	NULL
decreased	NULL
secondary	NULL
to	NULL
enhanced	NULL
protein	NULL
degradation	NULL
.	NULL

This	NULL
parallels	NULL
the	NULL
increased	NULL
IxBa	NULL
synthesis	NULL
secondary	NULL
to	NULL
increased	NULL
gene	NULL
transcription	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
increased	NULL
RNA	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
its	NULL
promoter-enhancer	NULL
.	NULL

Another	NULL
protein	NULL
with	NULL
IB	NULL
function	NULL
,	NULL
p105	NULL
,	NULL
is	NULL
also	NULL
modified	NULL
in	NULL
HIV-infected	NULL
cells	NULL
:	NULL
p105	NULL
and	NULL
p50	NULL
steady-state	NULL
protein	NULL
levels	NULL
are	NULL
increased	NULL
as	NULL
a	NULL
result	NULL
of	NULL
increased	NULL
synthesis	NULL
and	NULL
proteolytic	NULL
processing	NULL
of	NULL
p105	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
p105	NULL
is	NULL
also	NULL
increased	NULL
in	NULL
infected	NULL
cells	NULL
and	NULL
is	NULL
also	NULL
mediated	NULL
by	NULL
NF-KB	NULL
through	NULL
a	NULL
specific	NULL
xB	NULL
motif	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
triple	NULL
autoregulatory	NULL
loop	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
involving	NULL
HIV	NULL
,	NULL
p105	NULL
and	NULL
p50	NULL
,	NULL
and	NULL
MAD3	NULL
,	NULL
with	NULL
the	NULL
end	NULL
result	NULL
of	NULL
persistent	NULL
NF-KB	NULL
activation	NULL
and	NULL
viral	NULL
persistence	NULL
.	NULL

Furthermore	NULL
,	NULL
persistent	NULL
HIV	NULL
infection	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
provides	NULL
a	NULL
useful	NULL
model	NULL
with	NULL
which	NULL
to	NULL
study	NULL
concomitant	NULL
modifica-	NULL
tions	NULL
of	NULL
different	NULL
IB	NULL
molecules	NULL
.	NULL

Human	NULL
monocytes	NULL
and	NULL
macrophages	NULL
are	NULL
persistent	NULL
reservoirs	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
(	NULL
20	NULL
,	NULL
26	NULL
,	NULL
27	NULL
,	NULL
39	NULL
,	NULL
47	NULL
,	NULL
48	NULL
,	NULL
54	NULL
)	NULL
.	NULL

While	NULL
high	NULL
numbers	NULL
of	NULL
productively	NULL
infected	NULL
macrophages	NULL
have	NULL
been	NULL
found	NULL
in	NULL
the	NULL
brain	NULL
(	NULL
39	NULL
)	NULL
and	NULL
lymph	NULL
nodes	NULL
(	NULL
54	NULL
)	NULL
of	NULL
infected	NULL
patients	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
mechanisms	NULL
regulating	NULL
HIV	NULL
persistence	NULL
in	NULL
these	NULL
relevant	NULL
host	NULL
cells	NULL
.	NULL

Viral	NULL
replication	NULL
is	NULL
in	NULL
part	NULL
controlled	NULL
by	NULL
specific	NULL
viral	NULL
proteins	NULL
.	NULL

Tat	NULL
,	NULL
a	NULL
regulatory	NULL
viral	NULL
protein	NULL
generated	NULL
in	NULL
the	NULL
first	NULL
cycles	NULL
of	NULL
viral	NULL
transcription	NULL
,	NULL
increases	NULL
and	NULL
sustains	NULL
viral	NULL
replication	NULL
by	NULL
acting	NULL
through	NULL
the	NULL
tar	NULL
region	NULL
in	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
16	NULL
,	NULL
22	NULL
,	NULL
35	NULL
,	NULL
44	NULL
)	NULL
.	NULL

In	NULL
some	NULL
models	NULL
,	NULL
tat	NULL
requires	NULL
the	NULL
interaction	NULL
with	NULL
cis-acting	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
LTR	NULL
and	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
cellular	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
NF-kB	NULL
and	NULL
Sp1	NULL
(	NULL
8	NULL
,	NULL
25	NULL
,	NULL
36	NULL
,	NULL
56	NULL
,	NULL
68	NULL
,	NULL
72	NULL
)	NULL
.	NULL

While	NULL
both	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
initial	NULL
LTR-driven	NULL
transcription	NULL
of	NULL
HIV	NULL
,	NULL
their	NULL
potential	NULL
function	NULL
in	NULL
regulating	NULL
viral	NULL
persistence	NULL
in	NULL
macrophages	NULL
remains	NULL
unknown	NULL
.	NULL

NF-KB	NULL
is	NULL
an	NULL
inducible	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
,	NULL
including	NULL
that	NULL
of	NULL
HIV	NULL
(	NULL
29	NULL
,	NULL
51	NULL
)	NULL
.	NULL

The	NULL
classic	NULL
NF-kB	NULL
complex	NULL
is	NULL
a	NULL
heterodimer	NULL
of	NULL
p50	NULL
(	NULL
NF-kB1	NULL
)	NULL
and	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
(	NULL
38	NULL
,	NULL
52	NULL
,	NULL
66	NULL
)	NULL
.	NULL

Each	NULL
subunit	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-re/	NULL
proto-oncogene	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Other	NULL
members	NULL
include	NULL
p52	NULL
(	NULL
NF-kB2	NULL
)	NULL
(	NULL
10	NULL
,	NULL
63	NULL
)	NULL
,	NULL
ReIB	NULL
(	NULL
19	NULL
,	NULL
61	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Drosophila	NULL
homolog	NULL
,	NULL
dorsal	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Different	NULL
homodimeric	NULL
and	NULL
heterodimeric	NULL
combinations	NULL
of	NULL
these	NULL
c-Rel-related	NULL
molecules	NULL
transactivate	NULL
specific	NULL
genes	NULL
in	NULL
response	NULL
to	NULL
different	NULL
cellular	NULL
activation	NULL
signals	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Much	NULL
of	NULL
this	NULL
activation	NULL
specificity	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
inhibitory	NULL
molecules	NULL
known	NULL
as	NULL
IxBs	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Ankyrin-containing	NULL
IkBs	NULL
inhibit	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
200	NULL
First	NULL
St.	NULL
SW	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
507	NULL
)	NULL
284-3747	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
507	NULL
)	NULL
284-3757	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
PAYA	NULL
@	NULL
MAYO.EDU	NULL
.	NULL

1500	NULL
the	NULL
transactivating	NULL
potential	NULL
of	NULL
Rel-related	NULL
molecules	NULL
by	NULL
their	NULL
sequestration	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

IxB	NULL
molecules	NULL
with	NULL
these	NULL
features	NULL
include	NULL
IKxBa	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
28	NULL
,	NULL
30	NULL
)	NULL
,	NULL
IxBB	NULL
(	NULL
74	NULL
)	NULL
,	NULL
pp40	NULL
(	NULL
17	NULL
)	NULL
,	NULL
IxBy	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
the	NULL
precursor	NULL
proteins	NULL
of	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
p105	NULL
(	NULL
NF-B1	NULL
)	NULL
and	NULL
p100	NULL
(	NULL
NF-	NULL
«	NULL
kB2	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
43	NULL
,	NULL
58	NULL
,	NULL
62	NULL
,	NULL
71	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
of	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
macrophage	NULL
li-brary	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
was	NULL
shown	NULL
to	NULL
specifically	NULL
inhibit	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Such	NULL
inhibition	NULL
is	NULL
mediated	NULL
by	NULL
physically	NULL
masking	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
within	NULL
p65	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
the	NULL
p50/p65	NULL
heterodimeric	NULL
complex	NULL
(	NULL
7	NULL
)	NULL
.	NULL

NF-kB	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
requires	NULL
at	NULL
least	NULL
its	NULL
dissociation	NULL
from	NULL
IxBa	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

While	NULL
the	NULL
mechanisms	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
xB/IxBa	NULL
dissociation	NULL
in	NULL
the	NULL
cytosol	NULL
remain	NULL
to	NULL
be	NULL
fully	NULL
characterized	NULL
,	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
occurring	NULL
at	NULL
the	NULL
time	NULL
of	NULL
its	NULL
dissociation	NULL
from	NULL
NF-kB	NULL
has	NULL
been	NULL
documented	NULL
in	NULL
vitro	NULL
(	NULL
26	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
6	NULL
,	NULL
15	NULL
,	NULL
24	NULL
,	NULL
69	NULL
,	NULL
71	NULL
)	NULL
preceding	NULL
its	NULL
degradation	NULL
by	NULL
cellular	NULL
proteases	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
53	NULL
,	NULL
70	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Whether	NULL
phosphorylation	NULL
is	NULL
necessary	NULL
for	NULL
subsequent	NULL
degradation	NULL
remains	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

p105	NULL
and	NULL
p100	NULL
generate	NULL
p50	NULL
and	NULL
p52	NULL
upon	NULL
proteolytic	NULL
cleavage	NULL
but	NULL
also	NULL
p65/	NULL
p50	NULL
or	NULL
p65/p52	NULL
complexes	NULL
when	NULL
p105	NULL
or	NULL
p100	NULL
,	NULL
respectively	NULL
,	NULL
binds	NULL
p65	NULL
(	NULL
43	NULL
,	NULL
58	NULL
,	NULL
62	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Which	NULL
stimuli	NULL
and	NULL
through	NULL
which	NULL
mechanisms	NULL
the	NULL
pool	NULL
of	NULL
p65	NULL
anchored	NULL
by	NULL
p105	NULL
and	NULL
p100	NULL
can	NULL
be	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
are	NULL
unknown	NULL
.	NULL

Therefore	NULL
,	NULL
p65/p50	NULL
or	NULL
p65/p52	NULL
complexes	NULL
can	NULL
be	NULL
regulated	NULL
in	NULL
the	NULL
cytosol	NULL
by	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
mechanisms	NULL
,	NULL
one	NULL
regulated	NULL
by	NULL
IxBa	NULL
and	NULL
the	NULL
other	NULL
regulated	NULL
by	NULL
p105	NULL
and	NULL
p100	NULL
.	NULL

Within	NULL
the	NULL
nucleus	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
regulates	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
products	NULL
of	NULL
many	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
(	NULL
3	NULL
,	NULL
41	NULL
)	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
(	NULL
p105	NULL
,	NULL
the	NULL
precursor	NULL
of	NULL
p50	NULL
[	NULL
62	NULL
,	NULL
73	NULL
]	NULL
)	NULL
and	NULL
IxBa	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
40	NULL
,	NULL
57	NULL
,	NULL
65	NULL
,	NULL
70	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
genes	NULL
encoding	NULL
p105	NULL
and	NULL
IxBa	NULL
contain	NULL
functional	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
binding	NULL
sequences	NULL
(	NULL
40	NULL
,	NULL
73	NULL
)	NULL
,	NULL
and	NULL
p100	NULL
transcription	NULL
is	NULL
NF-kB	NULL
dependent	NULL
(	NULL
71	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
transloca-	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
tion	NULL
of	NULL
NF-kB	NULL
following	NULL
cell	NULL
activation	NULL
increases	NULL
IxBa	NULL
,	NULL
p105	NULL
,	NULL
and	NULL
p100	NULL
transcription	NULL
,	NULL
replenishing	NULL
the	NULL
cytoplasmic	NULL
store	NULL
of	NULL
such	NULL
proteins	NULL
.	NULL

Newly	NULL
assembled	NULL
NF-	NULL
«	NULL
B	NULL
will	NULL
bind	NULL
IxBa	NULL
and/or	NULL
p105	NULL
,	NULL
becoming	NULL
anchored	NULL
in	NULL
the	NULL
cytosol	NULL
and	NULL
restoring	NULL
the	NULL
cell	NULL
to	NULL
a	NULL
prestimulatory	NULL
(	NULL
resting	NULL
)	NULL
state	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
U937	NULL
monocytic	NULL
cells	NULL
results	NULL
in	NULL
increased	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
1	NULL
,	NULL
55	NULL
,	NULL
60	NULL
)	NULL
.	NULL

The	NULL
impact	NULL
of	NULL
this	NULL
interaction	NULL
in	NULL
favoring	NULL
viral	NULL
persistence	NULL
is	NULL
unknown	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NF-kB	NULL
activation	NULL
by	NULL
HIV	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV	NULL
persistence	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
we	NULL
need	NULL
to	NULL
more	NULL
fully	NULL
understand	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
HIV	NULL
activates	NULL
NF-kB	NULL
,	NULL
and	NULL
in	NULL
particular	NULL
,	NULL
if	NULL
these	NULL
mechanisms	NULL
are	NULL
similar	NULL
to	NULL
the	NULL
ones	NULL
previously	NULL
described	NULL
for	NULL
transient	NULL
stimuli	NULL
(	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
[	NULL
PMA	NULL
]	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
[	NULL
TNF	NULL
]	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
investigate	NULL
such	NULL
mechanisms	NULL
in	NULL
more	NULL
physiologically	NULL
and	NULL
relevant	NULL
human	NULL
host	NULL
cells	NULL
of	NULL
HIV	NULL
such	NULL
as	NULL
macrophages	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
performed	NULL
a	NULL
systematic	NULL
analysis	NULL
of	NULL
the	NULL
different	NULL
levels	NULL
of	NULL
NF-kB	NULL
regulation	NULL
in	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
,	NULL
more	NULL
importantly	NULL
,	NULL
in	NULL
human	NULL
macrophages	NULL
by	NULL
focusing	NULL
in	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranslational	NULL
regulation	NULL
of	NULL
IxBa	NULL
and	NULL
p105	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
HIV	NULL
infection	NULL
enhances	NULL
NF-	NULL
«	NULL
kB	NULL
DNA	NULL
binding	NULL
not	NULL
only	NULL
in	NULL
U937	NULL
monocytic	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
human	NULL
macrophages	NULL
.	NULL

Analysis	NULL
of	NULL
p105	NULL
and	NULL
p50	NULL
demonstrates	NULL
increased	NULL
steady-state	NULL
protein	NULL
levels	NULL
secondary	NULL
to	NULL
increased	NULL
protein	NULL
synthesis	NULL
of	NULL
p105	NULL
and	NULL
subsequent	NULL
proteolysis	NULL
to	NULL
p50	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
secondary	NULL
to	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
p105	NULL
promoter	NULL
through	NULL
a	NULL
specific	NULL
xB	NULL
motif	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
steady-state	NULL
protein	NULL
levels	NULL
of	NULL
IxBa	NULL
are	NULL
decreased	NULL
in	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
as	NULL
a	NULL
result	NULL
of	NULL
increased	NULL
degradation	NULL
.	NULL

Increased	NULL
IxBa	NULL
synthesis	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
kB	NULL
dependent	NULL
transcriptional	NULL
mechanisms	NULL
compensates	NULL
for	NULL
the	NULL
increased	NULL
proteolysis	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
HIV	NULL
infection	NULL
in	NULL
monocytes/macrophages	NULL
results	NULL
in	NULL
a	NULL
chronic	NULL
and	NULL
persistent	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
means	NULL
of	NULL
a	NULL
triple	NULL
positive	NULL
autoregulatory	NULL
loop	NULL
composed	NULL
of	NULL
p105	NULL
,	NULL
IxBa	NULL
,	NULL
and	NULL
HIV	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
HIV	NULL
infection	NULL
.	NULL

U937	NULL
promonocytic	NULL
cells	NULL
(	NULL
purchased	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
with	NULL
5	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Intergen	NULL
)	NULL
,	NULL
infected	NULL
with	NULL
the	NULL
HIV	NULL
LAV-Bru	NULL
strain	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
1	NULL
,	NULL
55	NULL
)	NULL
,	NULL
and	NULL
studied	NULL
from	NULL
days	NULL
30	NULL
to	NULL
90	NULL
postinfection	NULL
.	NULL

During	NULL
this	NULL
period	NULL
,	NULL
infected	NULL
cells	NULL
are	NULL
over	NULL
95	NULL
%	NULL
viable	NULL
.	NULL

Human	NULL
macrophages	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Hypaque	NULL
gradient	NULL
separation	NULL
from	NULL
buffy	NULL
coats	NULL
obtained	NULL
from	NULL
our	NULL
blood	NULL
bank	NULL
.	NULL

A	NULL
total	NULL
of	NULL
75	NULL
x	NULL
10°	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
10	NULL
%	NULL
human	NULL
AB	NULL
serum	NULL
(	NULL
Gibco	NULL
)	NULL
for	NULL
5	NULL
days	NULL
in	NULL
T75	NULL
flasks	NULL
.	NULL

Thereafter	NULL
,	NULL
nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
the	NULL
adherent	NULL
population	NULL
was	NULL
infected	NULL
with	NULL
monocytotropic	NULL
HIV	NULL
strains	NULL
(	NULL
JR/FL	NULL
and	NULL
SF/162	NULL
)	NULL
obtained	NULL
from	NULL
the	NULL
AIDS	NULL
Reference	NULL
and	NULL
Reagent	NULL
Repository	NULL
.	NULL

Over	NULL
95	NULL
%	NULL
of	NULL
adherent	NULL
cells	NULL
are	NULL
positive	NULL
for	NULL
nonspecific	NULL
sterase	NULL
and	NULL
CD14	NULL
surface	NULL
expression	NULL
.	NULL

Macrophages	NULL
were	NULL
harvested	NULL
3	NULL
to	NULL
4	NULL
weeks	NULL
postinfection	NULL
.	NULL

HIV	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
was	NULL
monitored	NULL
by	NULL
reverse	NULL
transcriptase	NULL
activity	NULL
and	NULL
p24	NULL
assays	NULL
(	NULL
Cellular	NULL
Products	NULL
,	NULL
Inc.	NULL
,	NULL
Buffalo	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
U937	NULL
cells	NULL
and	NULL
macrophages	NULL
infected	NULL
at	NULL
the	NULL
time	NULL
of	NULL
harvesting	NULL
was	NULL
determined	NULL
by	NULL
permeabilizing	NULL
the	NULL
cells	NULL
and	NULL
labeling	NULL
them	NULL
with	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
p24	NULL
(	NULL
Virostat	NULL
,	NULL
Portland	NULL
,	NULL
Maine	NULL
)	NULL
.	NULL

Flu-orescence-activated	NULL
cell	NULL
sorting	NULL
analysis	NULL
revealed	NULL
a	NULL
significant	NULL
shift	NULL
in	NULL
the	NULL
entire	NULL
population	NULL
(	NULL
a	NULL
single	NULL
shifted	NULL
peak	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
over	NULL
80	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
HIV	NULL
infected	NULL
.	NULL

As	NULL
previously	NULL
described	NULL
(	NULL
1	NULL
,	NULL
49	NULL
,	NULL
50	NULL
,	NULL
55	NULL
)	NULL
,	NULL
HIV	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
and	NULL
macrophages	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
known	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
TNF-a	NULL
,	NULL
interleukin-1	NULL
,	NULL
and	NULL
interleukin-6	NULL
)	NULL
.	NULL

Reagents	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
from	NULL
Escherichia	NULL
coli	NULL
O127	NULL
:	NULL
B8	NULL
was	NULL
obtained	NULL
from	NULL
Difco	NULL
(	NULL
Detroit	NULL
,	NULL
Mich.	NULL
)	NULL
and	NULL
stored	NULL
in	NULL
water	NULL
at	NULL
-20°C	NULL
.	NULL

PMA	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

and	NULL
stored	NULL
in	NULL
dimethy	NULL
sulfoxide	NULL
at	NULL
-20°C	NULL
.	NULL

TNF	NULL
was	NULL
obtained	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

and	NULL
stored	NULL
in	NULL
aliquots	NULL
at	NULL
-70°C	NULL
.	NULL

Nuclear	NULL
extraction	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
protein	NULL
was	NULL
extracted	NULL
by	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
then	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
N-2-hydroxycthylpiperazinc-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
]	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
dithioth-reitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
2	NULL
g	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
wg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lysed	NULL
with	NULL
buffer	NULL
A	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
for	NULL
4	NULL
IxBa	NULL
AND	NULL
p105	NULL
REGULATION	NULL
IN	NULL
HIV-INFECTED	NULL
MACROPHAGES	NULL
1501	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
buffer	NULL
A	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
20	NULL
al	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
25	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
glycerol	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Following	NULL
centrifugation	NULL
,	NULL
the	NULL
resultant	NULL
supernatant	NULL
was	NULL
diluted	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
20	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
glycerol	NULL
,	NULL
0.05	NULL
M	NULL
KCI	NULL
,	NULL
0.2	NULL
M	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
pepstatin	NULL
)	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

For	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
4	NULL
to	NULL
6	NULL
ug	NULL
of	NULL
protein	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
[	NULL
y	NULL
``	NULL
``	NULL
PJATP-labeled	NULL
double-stranded	NULL
oligode-oxynucleotide	NULL
probe	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
in	NULL
10	NULL
to	NULL
15	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
1	NULL
,	NULL
55	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
nondenaturing	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

DNA	NULL
binding	NULL
competition	NULL
was	NULL
assessed	NULL
by	NULL
preincubating	NULL
the	NULL
extract	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

The	NULL
oligonucleotide	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
corresponded	NULL
to	NULL
the	NULL
NF-kB	NULL
binding	NULL
sequence	NULL
present	NULL
within	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
5'-ACAAGGGACTTTCCGCT	NULL
GGGGACTTTCCAGGGA-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
double-stranded	NULL
probe	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
«	NULL
-*°P	NULL
]	NULL
dCTP	NULL
by	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Cytosolic	NULL
extracts	NULL
and	NULL
Western	NULL
blots	NULL
(	NULL
immunoblots	NULL
)	NULL
.	NULL

Cytosolic	NULL
proteins	NULL
were	NULL
obtained	NULL
from	NULL
0.5	NULL
X	NULL
10	NULL
``	NULL
to	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
500	NULL
mM	NULL
sucrose	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
B-mercaptocthanol	NULL
BME	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
4	NULL
min	NULL
.	NULL

The	NULL
resultant	NULL
supernatant	NULL
contained	NULL
cytosolic	NULL
proteins	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Amount	NULL
of	NULL
proteins	NULL
was	NULL
calculated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
,	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

These	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
membranes	NULL
(	NULL
Millipore	NULL
)	NULL
by	NULL
standard	NULL
procedures	NULL
.	NULL

Immunoblotting	NULL
was	NULL
done	NULL
and	NULL
visualized	NULL
by	NULL
using	NULL
an	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
kit	NULL
(	NULL
Am-ersham	NULL
)	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analysis	NULL
.	NULL

Cells	NULL
10	NULL
``	NULL
were	NULL
washed	NULL
with	NULL
0.14	NULL
M	NULL
NaCl	NULL
and	NULL
resuspended	NULL
in	NULL
20	NULL
mM	NULL
sodium	NULL
acetate	NULL
to	NULL
0.5	NULL
%	NULL
SDS	NULL
.	NULL

The	NULL
same	NULL
volume	NULL
of	NULL
water-saturated	NULL
phenol	NULL
was	NULL
added	NULL
and	NULL
mixed	NULL
by	NULL
shaking	NULL
in	NULL
a	NULL
65°C	NULL
water	NULL
bath	NULL
(	NULL
3	NULL
min	NULL
)	NULL
.	NULL

The	NULL
sample	NULL
was	NULL
then	NULL
placed	NULL
in	NULL
an	NULL
ethanol-dry	NULL
ice	NULL
bath	NULL
until	NULL
it	NULL
started	NULL
to	NULL
freeze	NULL
,	NULL
warmed	NULL
up	NULL
to	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
centrifuged	NULL
.	NULL

The	NULL
phenol	NULL
treatment	NULL
was	NULL
repeated	NULL
on	NULL
the	NULL
upper	NULL
phase	NULL
,	NULL
and	NULL
the	NULL
RNA	NULL
was	NULL
precipitated	NULL
with	NULL
sodium	NULL
acetate	NULL
and	NULL
ethanol	NULL
.	NULL

It	NULL
was	NULL
then	NULL
electrophoresed	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
Hybond-N+	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
*°P-labeled	NULL
probes	NULL
.	NULL

The	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
probe	NULL
consisted	NULL
of	NULL
a	NULL
1.3-kb	NULL
EcoRI-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
MAD3	NULL
cDNA	NULL
(	NULL
provided	NULL
by	NULL
Chiron	NULL
Corporation	NULL
)	NULL
,	NULL
and	NULL
the	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
probe	NULL
consisted	NULL
of	NULL
a	NULL
1.3-kb	NULL
Psfl	NULL
fragment	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Both	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-*°P	NULL
]	NULL
dCTP	NULL
by	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Bochringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Plasmids	NULL
.	NULL

Plasmid	NULL
1.2	NULL
HN-luc	NULL
(	NULL
wild-type	NULL
p105	NULL
)	NULL
consisted	NULL
of	NULL
the	NULL
1.2-kb	NULL
Hin-dIII-Ncol	NULL
fragment	NULL
of	NULL
the	NULL
p105	NULL
genomic	NULL
clone	NULL
inserted	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
plasmid	NULL
pe-lue	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
as	NULL
described	NULL
before	NULL
(	NULL
73	NULL
)	NULL
.	NULL

A	NULL
«	NULL
B1-1.2	NULL
HN-luc	NULL
,	NULL
A	NULL
«	NULL
B2-1.2	NULL
HN-luc	NULL
,	NULL
and	NULL
AHIP1	NULL
1.2	NULL
HN-luc	NULL
contained	NULL
the	NULL
same	NULL
insert	NULL
as	NULL
1.2	NULL
HN-luc	NULL
with	NULL
deletions	NULL
of	NULL
«	NULL
B1	NULL
(	NULL
-72	NULL
to	NULL
-61	NULL
)	NULL
,	NULL
«	NULL
B2	NULL
(	NULL
118	NULL
to	NULL
128	NULL
)	NULL
,	NULL
and	NULL
«	NULL
B3/HIP1	NULL
(	NULL
213	NULL
to	NULL
227	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

«	NULL
B3m-1.2	NULL
HN-luc	NULL
and	NULL
HIP1m-1.2	NULL
HN-lue	NULL
contained	NULL
the	NULL
same	NULL
insert	NULL
as	NULL
described	NULL
above	NULL
,	NULL
with	NULL
mutations	NULL
5	NULL
'	NULL
of	NULL
the	NULL
«	NULL
B3	NULL
(	NULL
213	NULL
to	NULL
217	NULL
)	NULL
and	NULL
3	NULL
'	NULL
of	NULL
the	NULL
HIP1	NULL
(	NULL
223	NULL
to	NULL
227	NULL
)	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

HindIII-Xbal-gener-ated	NULL
1.2-kb	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
plasmid	NULL
pe-luc	NULL
.	NULL

Orientation	NULL
of	NULL
the	NULL
inserts	NULL
was	NULL
verified	NULL
by	NULL
restriction	NULL
mapping	NULL
and	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
B1	NULL
,	NULL
«	NULL
B2	NULL
,	NULL
and	NULL
HIP1	NULL
deletions	NULL
and	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
HIP1	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
1.2-kb	NULL
HindIII-Neol	NULL
fragment	NULL
(	NULL
cloned	NULL
into	NULL
Bluescript	NULL
SK+	NULL
[	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
]	NULL
)	NULL
by	NULL
using	NULL
the	NULL
Mutagene	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
as	NULL
instructed	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
as	NULL
primers	NULL
were	NULL
synthesized	NULL
in	NULL
an	NULL
Applied	NULL
Biosystems	NULL
model	NULL
394	NULL
DNA	NULL
synthesizer	NULL
and	NULL
consisted	NULL
of	NULL
23	NULL
to	NULL
39	NULL
nucleotides	NULL
flanking	NULL
the	NULL
target	NULL
sites	NULL
for	NULL
deletion	NULL
or	NULL
muta-tion	NULL
:	NULL
A	NULL
«	NULL
B1	NULL
[	NULL
5CAGGCGCTITTCCT	NULL
(	NULL
GGGGGCTTCCC	NULL
)	NULL
TACCGGCTCCAG3	NULL
'	NULL
]	NULL
,	NULL
A	NULL
«	NULL
xB2	NULL
[	NULL
5CCCTAGAAGTGC	NULL
(	NULL
GGGCTTCCCC	NULL
)	NULL
CACCCCCGGC3	NULL
'	NULL
]	NULL
,	NULL
AHIPI	NULL
[	NULL
SACGTCAGTGGGA	NULL
(	NULL
ATTTCCAGCCA	NULL
)	NULL
GGAAGTGAGAGAY	NULL
'	NULL
)	NULL
,	NULL
«	NULL
B3m	NULL
(	NULL
5°CAGTCTCCATTTCCAGCCAGGAAF	NULL
'	NULL
)	NULL
,	NULL
and	NULL
HIP1m	NULL
(	NULL
5'GTGGGAATTTC	NULL
CGCTAGGGAAGTGAGA3	NULL
'	NULL
)	NULL
(	NULL
lowercase	NULL
)	NULL
letters	NULL
and	NULL
underlining	NULL
indicate	NULL
the	NULL
native	NULL
sequence	NULL
to	NULL
be	NULL
deleted	NULL
,	NULL
and	NULL
italicized	NULL
boldface	NULL
letters	NULL
indicate	NULL
mutations	NULL
to	NULL
be	NULL
introduced	NULL
in	NULL
the	NULL
native	NULL
sequence	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
or	NULL
deleted	NULL
clones	NULL
were	NULL
verified	NULL
by	NULL
sequencing	NULL
using	NULL
Sequenase	NULL
2.0	NULL
(	NULL
United	NULL
States	NULL
Biochemical	NULL
,	NULL
Cleve-land	NULL
,	NULL
Ohio	NULL
)	NULL
.	NULL

Plasmid	NULL
«	NULL
B-luc	NULL
contains	NULL
three	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
xB	NULL
motif	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
cloned	NULL
upstream	NULL
of	NULL
plasmid	NULL
cona-luc	NULL
.	NULL

Plasmid	NULL
MAD3-luc	NULL
contains	NULL
nucleotides	NULL
-385	NULL
to	NULL
+78	NULL
of	NULL
the	NULL
MAD3	NULL
cDNA	NULL
cloned	NULL
into	NULL
the	NULL
Secl-KprI	NULL
site	NULL
of	NULL
pGL2-Basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Plasmid	NULL
MAD3AxB	NULL
is	NULL
the	NULL
same	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
xB	NULL
motif	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
-B-galactosidase	NULL
(	NULL
B-Gal	NULL
)	NULL
plasmid	NULL
is	NULL
a	NULL
mammalian	NULL
reporter	NULL
vector	NULL
designed	NULL
for	NULL
expression	NULL
of	NULL
B-Gal	NULL
in	NULL
mammalian	NULL
cells	NULL
as	NULL
transcribed	NULL
by	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
TK	NULL
minimal	NULL
promoter	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

The	NULL
antibodies	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
included	NULL
polyclonal	NULL
anti-p50	NULL
(	NULL
28	NULL
)	NULL
and	NULL
anti-c-Rel	NULL
and	NULL
anti-p65	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Antibodies	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
antibodies	NULL
.	NULL

Western	NULL
blotting	NULL
and	NULL
immunoprecipitation	NULL
were	NULL
performed	NULL
with	NULL
polyclonal	NULL
anti-p50	NULL
,	NULL
anti-p65	NULL
,	NULL
and	NULL
anti-IxBa	NULL
MAD3	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Antibodies	NULL
)	NULL
sera	NULL
.	NULL

In	NULL
some	NULL
exper-	NULL
1502	NULL
McELHINNY	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

U937	NULL
cells	NULL
macrophages	NULL
NI	NULL
|	NULL
HIV	NULL
NI	NULL
__	NULL
;	NULL
___	NULL
HIV	NULL
ANTIBODY	NULL
-	NULL
p50	NULL
-	NULL
-	NULL
pSOpe5	NULL
-	NULL
-	NULL
PBO	NULL
p65	NULL
-	NULL
-	NULL
p30	NULL
p65	NULL
COMPETI	NULL
NON	NULL
Infonet	NULL
s	NULL
-o-	NULL
-	NULL
Rok	NULL
e	NULL
poe	NULL
-	NULL
-	NULL
#	NULL
a	NULL
.	NULL

.	NULL

®	NULL
w	NULL
im	NULL
-	NULL
péS/pS0	NULL
pes/p50	NULL
-	NULL
T	NULL
pS0/pS0	NULL
_-	NULL
-	NULL
>	NULL
'	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequences	NULL
of	NULL
the	NULL
enhancer	NULL
region	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
proteins	NULL
extracted	NULL
from	NULL
non	NULL
infected	NULL
(	NULL
NI	NULL
)	NULL
and	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
(	NULL
6	NULL
pg	NULL
per	NULL
sample	NULL
)	NULL
and	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
macrophages	NULL
(	NULL
4	NULL
jg	NULL
per	NULL
sample	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
13	NULL
,	NULL
nuclear	NULL
extract	NULL
only	NULL
;	NULL
2	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
14	NULL
,	NULL
nuclear	NULL
extract	NULL
preincubated	NULL
with	NULL
anti-p50	NULL
;	NULL
3	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
and	NULL
15	NULL
,	NULL
nuclear	NULL
extract	NULL
preincubated	NULL
with	NULL
anti-p65	NULL
;	NULL
4	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
and	NULL
16	NULL
,	NULL
nuclear	NULL
extract	NULL
preincubated	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
each	NULL
bands	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
and	NULL
right	NULL
.	NULL

iments	NULL
,	NULL
a	NULL
polyclonal	NULL
anti-IxBa	NULL
«	NULL
(	NULL
MAD3	NULL
)	NULL
serum	NULL
generated	NULL
by	NULL
using	NULL
a	NULL
glutathione	NULL
S-transferase-MAD3	NULL
fusion	NULL
protein	NULL
or	NULL
an	NULL
anti-p105/p50	NULL
serum	NULL
raised	NULL
against	NULL
a	NULL
glutathione	NULL
S-transferase-p105	NULL
fusion	NULL
was	NULL
also	NULL
used	NULL
.	NULL

Transfections	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
per	NULL
point	NULL
)	NULL
were	NULL
electroporated	NULL
with	NULL
5	NULL
to	NULL
10	NULL
pg	NULL
of	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
and	NULL
10	NULL
g	NULL
of	NULL
control	NULL
TK-B-Gal	NULL
,	NULL
using	NULL
a	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
Cell-Porator	NULL
(	NULL
800	NULL
wF	NULL
and	NULL
300	NULL
V	NULL
)	NULL
;	NULL
2	NULL
x	NULL
10°	NULL
transfected	NULL
cells	NULL
were	NULL
harvested	NULL
8	NULL
h	NULL
later	NULL
,	NULL
using	NULL
cell	NULL
culture	NULL
lysis	NULL
reagent	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
,	NULL
and	NULL
B-Gal	NULL
activity	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
the	NULL
Tropix	NULL
Galacto-Light	NULL
reporter	NULL
assay	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
rest	NULL
of	NULL
the	NULL
sample	NULL
(	NULL
8	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
was	NULL
harvested	NULL
by	NULL
the	NULL
same	NULL
procedure	NULL
16	NULL
to	NULL
20	NULL
h	NULL
later	NULL
,	NULL
and	NULL
luciferase	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
using	NULL
the	NULL
Promega	NULL
luciferase	NULL
assay	NULL
system	NULL
.	NULL

Both	NULL
B-Gal	NULL
and	NULL
luciferase	NULL
were	NULL
measured	NULL
in	NULL
a	NULL
Berthold	NULL
Lumat	NULL
.	NULL

Total	NULL
protein	NULL
in	NULL
an	NULL
aliquot	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
technique	NULL
(	NULL
Bio-Rad	NULL
)	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
luciferase	NULL
units/B-Gal	NULL
units	NULL
.	NULL

[	NULL
**S	NULL
]	NULL
methionine	NULL
labeling	NULL
and	NULL
i	NULL
p	NULL
ion	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
per	NULL
point	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
methionine-free	NULL
medium	NULL
(	NULL
ICN	NULL
)	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
labeled	NULL
with	NULL
1	NULL
mCi	NULL
of	NULL
[	NULL
*°S	NULL
)	NULL
methionine-cysteine	NULL
(	NULL
32	NULL
X	NULL
10°	NULL
)	NULL
cells	NULL
for	NULL
different	NULL
time	NULL
peri-ods	NULL
.	NULL

For	NULL
chase	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
in	NULL
regular	NULL
(	NULL
methionine-	NULL
and	NULL
cysteine-containing	NULL
)	NULL
medium	NULL
for	NULL
different	NULL
lengths	NULL
of	NULL
time	NULL
.	NULL

Cytosolic	NULL
fractions	NULL
were	NULL
obtained	NULL
by	NULL
lysing	NULL
cells	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
(	NULL
pH	NULL
7.5	NULL
;	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
were	NULL
obtained	NULL
by	NULL
using	NULL
a	NULL
radioimmunoprecipitation	NULL
assay	NULL
lysis	NULL
buffer	NULL
(	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
0.5	NULL
%	NULL
deoxycholate	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
2	NULL
g	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
2	NULL
pg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
precleared	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
the	NULL
specific	NULL
antibody	NULL
.	NULL

Protein	NULL
G-agarose	NULL
beads	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
were	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
and	NULL
washed	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
was	NULL
eluted	NULL
.	NULL

These	NULL
eluants	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
membranes	NULL
(	NULL
Millipore	NULL
)	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
and/or	NULL
immunoblotting	NULL
.	NULL

RESULTS	NULL
Increased	NULL
NF-KB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
HIV-Infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Increased	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
has	NULL
been	NULL
described	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
infected	NULL
with	NULL
HIV	NULL
(	NULL
1	NULL
,	NULL
55	NULL
,	NULL
60	NULL
)	NULL
.	NULL

We	NULL
first	NULL
wanted	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
phenomenon	NULL
is	NULL
present	NULL
in	NULL
a	NULL
more	NULL
relevant	NULL
host	NULL
cell	NULL
such	NULL
as	NULL
macrophages	NULL
.	NULL

Human	NULL
macrophages	NULL
derived	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
mock	NULL
infected	NULL
(	NULL
supernatant	NULL
of	NULL
phytohemag-glutinin-interleukin-2-treated	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
virus	NULL
)	NULL
or	NULL
infected	NULL
with	NULL
the	NULL
HIV	NULL
strain	NULL
SF/162	NULL
.	NULL

HIV-infected	NULL
macrophages	NULL
contained	NULL
increased	NULL
NF-	NULL
«	NULL
kB	NULL
DNA	NULL
binding	NULL
as	NULL
shown	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Infection	NULL
with	NULL
other	NULL
monocytotropic	NULL
strains	NULL
such	NULL
as	NULL
JR/FL	NULL
,	NULL
Ada	NULL
,	NULL
and	NULL
Bal	NULL
also	NULL
resulted	NULL
in	NULL
NF-kB	NULL
activation	NULL
,	NULL
while	NULL
mock	NULL
infection	NULL
or	NULL
infection	NULL
with	NULL
LAV-Bru	NULL
did	NULL
not	NULL
result	NULL
in	NULL
HIV	NULL
infection	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
HIV-dependent	NULL
NF-kB	NULL
activation	NULL
present	NULL
in	NULL
human	NULL
macrophages	NULL
is	NULL
increased	NULL
over	NULL
the	NULL
baseline	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
nor	NULL
mally	NULL
present	NULL
in	NULL
human	NULL
macrophages	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
as	NULL
well	NULL
as	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
oligonucleotide	NULL
demonstrated	NULL
that	NULL
the	NULL
NF-kB-like	NULL
complex	NULL
present	NULL
in	NULL
both	NULL
HIV-infected	NULL
macrophages	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
consists	NULL
of	NULL
a	NULL
p50/p65	NULL
het-erodimer	NULL
.	NULL

The	NULL
anti-c-Rel	NULL
antibody	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
nuclear	NULL
DNA-binding	NULL
complex	NULL
,	NULL
while	NULL
it	NULL
upshifted	NULL
a	NULL
DNA-binding	NULL
complex	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
the	NULL
B-cell	NULL
line	NULL
BJAB	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IxBa	NULL
undergoes	NULL
posttranslational	NULL
modifications	NULL
in	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Having	NULL
shown	NULL
that	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
occurs	NULL
not	NULL
only	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
but	NULL
also	NULL
in	NULL
a	NULL
more	NULL
relevant	NULL
host	NULL
cell	NULL
target	NULL
such	NULL
as	NULL
human	NULL
macrophages	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
whether	NULL
IxB	NULL
molecules	NULL
are	NULL
regulated	NULL
by	NULL
persistent	NULL
HIV	NULL
infection	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

IxBa	NULL
is	NULL
one	NULL
key	NULL
molecule	NULL
in	NULL
regulating	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nuclei	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
transient	NULL
cell	NULL
stimuli	NULL
such	NULL
as	NULL
TNF	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
12	NULL
,	NULL
70	NULL
)	NULL
result	NULL
in	NULL
its	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
24	NULL
,	NULL
57	NULL
,	NULL
70	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Immunoblotting	NULL
experiments	NULL
of	NULL
cytosolic	NULL
fractions	NULL
from	NULL
HIV-infected	NULL
and	NULL
uninfected	NULL
U937	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
demonstrate	NULL
that	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
IxBa	NULL
are	NULL
persistently	NULL
decreased	NULL
in	NULL
infected	NULL
compared	NULL
with	NULL
uninfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
decreased	NULL
cytosolic	NULL
IxBa	NULL
in	NULL
infected	NULL
cells	NULL
is	NULL
secondary	NULL
to	NULL
decreased	NULL
protein	NULL
synthesis	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
results	NULL
from	NULL
increased	NULL
protein	NULL
degradation	NULL
as	NULL
would	NULL
be	NULL
expected	NULL
following	NULL
treatment	NULL
with	NULL
stimuli	NULL
such	NULL
as	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
pulse-chase	NULL
[	NULL
°°S	NULL
]	NULL
methionine-cysteine	NULL
labeling	NULL
experiments	NULL
followed	NULL
by	NULL
IkxBa	NULL
immunoprecipitation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
indicate	NULL
that	NULL
both	NULL
the	NULL
synthesis	NULL
rate	NULL
(	NULL
pulse	NULL
time	NULL
,	NULL
0	NULL
min	NULL
)	NULL
and	NULL
IxBa	NULL
degradation	NULL
(	NULL
60-	NULL
and	NULL
180-min	NULL
chases	NULL
are	NULL
increased	NULL
in	NULL
infected	NULL
cells	NULL
compared	NULL
with	NULL
uninfected	NULL
cells	NULL
.	NULL

To	NULL
specifically	NULL
analyze	NULL
whether	NULL
the	NULL
IxBa	NULL
molecule	NULL
suscegtible	NULL
to	NULL
degradation	NULL
was	NULL
associated	NULL
with	NULL
NF-kB	NULL
,	NULL
additional	NULL
*°S	NULL
pulse-chase	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
entire	NULL
complex	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
anti-p65	NULL
or	NULL
anti-p105/p50	NULL
antibody	NULL
.	NULL

Increased	NULL
IxBa	NULL
synthesis	NULL
(	NULL
pulse	NULL
time	NULL
,	NULL
0	NULL
min	NULL
)	NULL
and	NULL
degradation	NULL
(	NULL
180-mm	NULL
chase	NULL
)	NULL
were	NULL
present	NULL
while	NULL
the	NULL
protein	NULL
was	NULL
associated	NULL
with	NULL
NF-kB	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
immunoprecipitating	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
or	NULL
p105/p50	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
half-lives	NULL
of	NULL
calculated	NULL
from	NULL
Fig	NULL
.	NULL

2B	NULL
were	NULL
187	NULL
mm	NULL
in	NULL
uninfected	NULL
cells	NULL
and	NULL
103	NULL
min	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
Fig	NULL
.	NULL

2C	NULL
and	NULL
4B	NULL
.	NULL

Whether	NULL
increased	NULL
IxBa	NULL
degradation	NULL
in	NULL
infected	NULL
cells	NULL
is	NULL
secondary	NULL
to	NULL
its	NULL
phosphorylation	NULL
by	NULL
a	NULL
specific	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
A	NULL
U937	NULL
_	NULL
macroph	NULL
.	NULL

B	NULL
Ni	NULL
LPs	NULL
HIV	NULL
-	NULL
NI	NULL
HIV	NULL
IP	NULL
with	NULL
o	NULL
:	NULL
IcBo	NULL
:	NULL
NI	NULL
HIV	NULL
.	NULL

£	NULL
minutes	NULL
:	NULL
0	NULL
60	NULL
180	NULL
0	NULL
60	NULL
180	NULL
IxBo	NULL
:	NULL
-	NULL
(	NULL
wie	NULL
|_	NULL
aus	NULL
.	NULL

a	NULL
»	NULL
2.14435	NULL
;	NULL
o-	NULL
tums	NULL
cuse	NULL
«	NULL
-+	NULL
IKBc	NULL
:	NULL
--	NULL
wom	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
C	NULL
IP	NULL
with	NULL
a	NULL
p65	NULL
NI	NULL
HIV	NULL
minutes	NULL
:	NULL
0	NULL
180	NULL
0	NULL
180	NULL
D	NULL
U937	NULL
macroph	NULL
.	NULL

pes	NULL
-	NULL
1	NULL
_L	NULL
Ei	NULL
24	NULL
NI	NULL
PMA	NULL
HIV	NULL
-	NULL
NI	NULL
HIV	NULL
hicBo	NULL
.	NULL

-	NULL
<	NULL
-	NULL
Wi	NULL
we	NULL
B4	NULL
``	NULL
GaPpH	NULL
m	NULL
IKBo	NULL
:	NULL
-	NULL
=	NULL
.	NULL

4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Cellular	NULL
sublocalization	NULL
,	NULL
synthesis	NULL
and	NULL
processing	NULL
,	NULL
and	NULL
steady-state	NULL
RNA	NULL
levels	NULL
of	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cytosolic	NULL
proteins	NULL
from	NULL
U937	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
were	NULL
extracted	NULL
,	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
,	NULL
and	NULL
immu-noblotted	NULL
with	NULL
anti-IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
antibodies	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
run	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
U937	NULL
cells	NULL
was	NULL
done	NULL
with	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
g/ml	NULL
for	NULL
2	NULL
h.	NULL
NL	NULL
,	NULL
noninfected	NULL
.	NULL

(	NULL
B	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
**SJmethi-onine	NULL
for	NULL
2	NULL
h	NULL
,	NULL
chased	NULL
with	NULL
unlabeled	NULL
methionine-containing	NULL
medium	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
,	NULL
lysed	NULL
,	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
anti-I	NULL
«	NULL
Ba	NULL
«	NULL
(	NULL
MAD3	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
*°	NULL
$	NULL
labeling	NULL
of	NULL
non-IxBa-related	NULL
proteins	NULL
were	NULL
equal	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

(	NULL
C	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
*°SJmethionine	NULL
for	NULL
20	NULL
min	NULL
,	NULL
chased	NULL
with	NULL
unlabeled	NULL
methionine-containing	NULL
medium	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
lysed	NULL
,	NULL
immunoprecipitated	NULL
with	NULL
anti-p65	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

(	NULL
D	NULL
)	NULL
RNA	NULL
from	NULL
U937	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
was	NULL
extracted	NULL
,	NULL
electrophoresed	NULL
,	NULL
transferred	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-labeled	NULL
MAD3	NULL
cDNA	NULL
probe	NULL
and	NULL
subsequently	NULL
with	NULL
a	NULL
*°P-labeled	NULL
GAPDH	NULL
probe	NULL
.	NULL

PMA	NULL
stimulation	NULL
of	NULL
U937	NULL
cells	NULL
was	NULL
done	NULL
with	NULL
a	NULL
concentration	NULL
of	NULL
20	NULL
ng/ml	NULL
for	NULL
2	NULL
h.	NULL
or	NULL
is	NULL
directly	NULL
caused	NULL
by	NULL
a	NULL
cellular	NULL
and/or	NULL
viral	NULL
protease	NULL
independently	NULL
from	NULL
phosphorylation	NULL
remains	NULL
unknown	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
IxBa	NULL
in	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

We	NULL
next	NULL
assessed	NULL
whether	NULL
increased	NULL
IxBa	NULL
synthesis	NULL
in	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
and	NULL
macrophages	NULL
is	NULL
secondary	NULL
to	NULL
increased	NULL
gene	NULL
transcription	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
indicates	NULL
that	NULL
steady-state	NULL
levels	NULL
of	NULL
IxBa	NULL
RNA	NULL
are	NULL
also	NULL
increased	NULL
in	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
compared	NULL
with	NULL
uninfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

To	NULL
further	NULL
determine	NULL
whether	NULL
such	NULL
increase	NULL
is	NULL
a	NULL
result	NULL
of	NULL
enhanced	NULL
gene	NULL
transcription	NULL
of	NULL
the	NULL
MAD3	NULL
enhancer-promoter	NULL
,	NULL
we	NULL
performed	NULL
transient	NULL
transfections	NULL
of	NULL
the	NULL
IxBa	NULL
promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
.	NULL

A	NULL
TK-B-Gal	NULL
reporter	NULL
gene	NULL
was	NULL
cotransfected	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
increased	NULL
NF-xB	NULL
activity	NULL
is	NULL
present	NULL
in	NULL
HIV-infected	NULL
cells	NULL
compared	NULL
with	NULL
uninfected	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
increased	NULL
luciferase	NULL
production	NULL
of	NULL
an	NULL
NF-kB	NULL
concatemer-luciferase	NULL
reporter	NULL
gene	NULL
which	NULL
is	NULL
also	NULL
upregulated	NULL
by	NULL
LPS	NULL
in	NULL
uninfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
IxBa	NULL
enhancer-promoter-luciferase	NULL
construct	NULL
is	NULL
transcriptionally	NULL
upregulated	NULL
both	NULL
in	NULL
HIV-infected	NULL
(	NULL
compared	NULL
with	NULL
uninfected	NULL
)	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
and	NULL
in	NULL
uninfected	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
IxBa	NULL
upregulation	NULL
by	NULL
HIV	NULL
is	NULL
NF-	NULL
«	NULL
B	NULL
dependent	NULL
,	NULL
a	NULL
deleted	NULL
IxBa	NULL
luciferase	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
xB	NULL
site	NULL
within	NULL
the	NULL
IxBa	NULL
promoter	NULL
significantly	NULL
reduces	NULL
the	NULL
HIV-me-diated	NULL
upregulation	NULL
of	NULL
the	NULL
wild-type	NULL
IxBa	NULL
promoter	NULL
as	NULL
well	NULL
as	NULL
IxBa	NULL
AND	NULL
p105	NULL
REGULATION	NULL
IN	NULL
HIV-INFECTED	NULL
MACROPHAGES	NULL
1503	NULL
that	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
increased	NULL
IxBa	NULL
synthesis	NULL
in	NULL
HIV-infected	NULL
cells	NULL
is	NULL
secondary	NULL
to	NULL
transcriptional	NULL
upregulation	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
by	NULL
NF-KB	NULL
itself	NULL
.	NULL

Regulation	NULL
of	NULL
p105	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Other	NULL
molecules	NULL
aside	NULL
from	NULL
IxBa	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

p105	NULL
and	NULL
p100	NULL
anchor	NULL
p65	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
inactive	NULL
pool	NULL
of	NULL
p65	NULL
.	NULL

Proteolytic	NULL
cleavage	NULL
of	NULL
each	NULL
precursor	NULL
potentially	NULL
leads	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
p65/pS50	NULL
and	NULL
p65/pS52	NULL
complexes	NULL
,	NULL
respectively	NULL
,	NULL
that	NULL
theoretically	NULL
,	NULL
are	NULL
then	NULL
free	NULL
to	NULL
undergo	NULL
nuclear	NULL
translocation	NULL
.	NULL

Even	NULL
though	NULL
our	NULL
data	NULL
point	NULL
to	NULL
IxBa	NULL
as	NULL
a	NULL
key	NULL
regulatory	NULL
molecule	NULL
targeted	NULL
by	NULL
persistent	NULL
HIV	NULL
infection	NULL
to	NULL
result	NULL
in	NULL
continuous	NULL
NF-KB	NULL
translocation	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
this	NULL
chronic	NULL
stimulus	NULL
also	NULL
regulates	NULL
other	NULL
functional	NULL
IxB	NULL
proteins	NULL
such	NULL
as	NULL
p105	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
the	NULL
steady-state	NULL
protein	NULL
level	NULL
of	NULL
p105	NULL
in	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
.	NULL

Cytosolic	NULL
fractions	NULL
of	NULL
infected	NULL
monocytic	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
contain	NULL
increased	NULL
steady-state	NULL
levels	NULL
of	NULL
p105	NULL
and	NULL
p50	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
p105	NULL
synthesis	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
the	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
p105	NULL
into	NULL
p50	NULL
are	NULL
upregulated	NULL
,	NULL
we	NULL
performed	NULL
metabolic	NULL
pulse-chase	NULL
labeling	NULL
experiments	NULL
using	NULL
[	NULL
**S	NULL
)	NULL
Jmethionine-cysteine	NULL
followed	NULL
by	NULL
p105/	NULL
p50	NULL
immunoprecipitation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
increased	NULL
synthesis	NULL
of	NULL
p105	NULL
is	NULL
already	NULL
present	NULL
in	NULL
total	NULL
cell	NULL
extracts	NULL
of	NULL
HIV-infected	NULL
cells	NULL
after	NULL
20	NULL
min	NULL
of	NULL
pulse-labeling	NULL
(	NULL
time	NULL
0	NULL
)	NULL
compared	NULL
with	NULL
uninfected	NULL
cells	NULL
.	NULL

Chase	NULL
with	NULL
unlabelled	NULL
methionine	NULL
and	NULL
cysteine	NULL
indicates	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
*°S-labeled	NULL
p105	NULL
is	NULL
not	NULL
modified	NULL
in	NULL
uninfected	NULL
cells	NULL
after	NULL
120	NULL
min	NULL
,	NULL
while	NULL
a	NULL
reduction	NULL
of	NULL
-labeled	NULL
p105	NULL
is	NULL
observed	NULL
within	NULL
the	NULL
same	NULL
period	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

*°S-p50	NULL
,	NULL
presumably	NULL
resulting	NULL
from	NULL
p105	NULL
proteolytic	NULL
processing	NULL
,	NULL
is	NULL
already	NULL
present	NULL
in	NULL
the	NULL
20-min	NULL
pulse	NULL
time	NULL
in	NULL
both	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
a	NULL
moderate	NULL
increase	NULL
in	NULL
°°8-p50	NULL
is	NULL
observed	NULL
in	NULL
the	NULL
chase	NULL
point	NULL
in	NULL
HIV-infected	NULL
cells	NULL
compared	NULL
with	NULL
uninfected	NULL
cells	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
result	NULL
,	NULL
p105	NULL
and	NULL
p50	NULL
*°S-labeled	NULL
bands	NULL
were	NULL
scanned	NULL
by	NULL
den-sitometry	NULL
.	NULL

The	NULL
ratios	NULL
of	NULL
p105	NULL
to	NULL
p50	NULL
in	NULL
uninfected	NULL
cells	NULL
were	NULL
0.492	NULL
and	NULL
0.486	NULL
for	NULL
the	NULL
pulse	NULL
and	NULL
chase	NULL
points	NULL
,	NULL
respectively	NULL
;	NULL
while	NULL
in	NULL
the	NULL
HIV-infected	NULL
cells	NULL
,	NULL
the	NULL
ratios	NULL
were	NULL
0.661	NULL
(	NULL
pulse	NULL
)	NULL
and	NULL
0.501	NULL
(	NULL
chase	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
p105	NULL
synthesis	NULL
is	NULL
increased	NULL
in	NULL
HIV-infected	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
processing	NULL
of	NULL
p105	NULL
into	NULL
p50	NULL
is	NULL
moderately	NULL
enhanced	NULL
in	NULL
these	NULL
cells	NULL
compared	NULL
with	NULL
uninfected	NULL
controls	NULL
.	NULL

Whether	NULL
induced	NULL
p105	NULL
proteolysis	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
viral	NULL
protease	NULL
directly	NULL
,	NULL
as	NULL
suggested	NULL
previously	NULL
in	NULL
acute	NULL
HIV	NULL
infection	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
59	NULL
)	NULL
,	NULL
or	NULL
by	NULL
cellular	NULL
protease	NULL
(	NULL
s	NULL
)	NULL
such	NULL
as	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
53	NULL
)	NULL
by	NULL
HIV	NULL
,	NULL
remains	NULL
unknown	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
mechanism	NULL
,	NULL
these	NULL
results	NULL
provide	NULL
evidence	NULL
that	NULL
a	NULL
persistent	NULL
stimulus	NULL
such	NULL
as	NULL
HIV	NULL
can	NULL
induce	NULL
the	NULL
modification	NULL
of	NULL
at	NULL
least	NULL
two	NULL
inhibitory	NULL
molecules	NULL
to	NULL
result	NULL
in	NULL
continuous	NULL
NF-kB	NULL
activation	NULL
.	NULL

p105	NULL
transcriptional	NULL
activity	NULL
is	NULL
upregulated	NULL
in	NULL
HIV-infected	NULL
monocytes	NULL
;	NULL
role	NULL
of	NULL
the	NULL
B3	NULL
motif	NULL
in	NULL
the	NULL
p105	NULL
enhancer-promoter	NULL
.	NULL

Increased	NULL
synthesis	NULL
of	NULL
p105	NULL
is	NULL
probably	NULL
regulated	NULL
by	NULL
transcriptional	NULL
mechanisms	NULL
as	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
case	NULL
of	NULL
IxBa	NULL
regulation	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Our	NULL
group	NULL
had	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
native	NULL
p105	NULL
enhancer-promoter	NULL
is	NULL
upregulated	NULL
by	NULL
NF-kB	NULL
and	NULL
that	NULL
its	NULL
transcriptional	NULL
activity	NULL
in	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
is	NULL
also	NULL
increased	NULL
(	NULL
55	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
from	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
indicates	NULL
increased	NULL
steady-state	NULL
RNA	NULL
of	NULL
p105	NULL
in	NULL
HIV-infected	NULL
cells	NULL
We	NULL
next	NULL
investigated	NULL
through	NULL
which	NULL
region	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
promoter-enhancer	NULL
of	NULL
the	NULL
p105	NULL
gene	NULL
was	NULL
mediating	NULL
its	NULL
upregulation	NULL
via	NULL
HIV	NULL
infection	NULL
.	NULL

To	NULL
do	NULL
so	NULL
,	NULL
a	NULL
detailed	NULL
study	NULL
of	NULL
the	NULL
different	NULL
kB	NULL
and	NULL
other	NULL
cis-acting	NULL
motifs	NULL
present	NULL
in	NULL
the	NULL
p105	NULL
promoter	NULL
was	NULL
performed	NULL
.	NULL

Rese-	NULL
1504	NULL
McELHINNY	NULL
ET	NULL
AL	NULL
.	NULL

03	NULL
[	NULL
-	NULL
]	NULL
¢	NULL
``	NULL
~	NULL
115	NULL
E	NULL
5000	NULL
A	NULL
g	NULL
4000	NULL
&	NULL
$	NULL
sow	NULL
g	NULL
o	NULL
2000	NULL
g	NULL
1000	NULL
$	NULL
3	NULL
1	NULL
1	NULL
8.70	NULL
3	NULL
04	NULL
-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
con	NULL
a	NULL
con	NULL
a	NULL
kB-luc	NULL
kB-luc	NULL
lue	NULL
lue	NULL
STIMULI	NULL
:	NULL
w=	NULL
HIV	NULL
wen	NULL
HIV	NULL
co	NULL
o	NULL
g	NULL
2000	NULL
'	NULL
C	NULL
2	NULL
C	NULL
47.0	NULL
C	NULL
p	NULL
c	NULL
£	NULL
10	NULL
&	NULL
3	NULL
0	NULL
8	NULL
§	NULL
1	NULL
1	NULL
-	NULL
8.30	NULL
3°	NULL
0	NULL
ql	NULL
_I	NULL
9	NULL
10	NULL
11	NULL
12	NULL
MAD3	NULL
MAD3	NULL
MAD3	NULL
MAD3	NULL
AKB	NULL
AKB	NULL
faved	NULL
HIV	NULL
«	NULL
==	NULL
HIV	NULL
J.	NULL
ViroL	NULL
.	NULL

5.44	NULL
$	NULL
a	NULL
8	NULL
Luciferase	NULL
Units/B-gal	NULL
Units,103	NULL
o	NULL
3	NULL
5	NULL
6	NULL
7	NULL
8	NULL
con	NULL
a	NULL
con	NULL
a	NULL
kB-lue	NULL
kB-luc	NULL
lue	NULL
lue	NULL
s=	NULL
LPS	NULL
wes	NULL
LPS	NULL
Luciferase	NULL
Units/B-gai	NULL
Units,103	NULL
13	NULL
14	NULL
15	NULL
16	NULL
MAD3	NULL
MAD3	NULL
MAD3	NULL
MAD3	NULL
AKB	NULL
AKB	NULL
==	NULL
LPS	NULL
«	NULL
-=	NULL
LPS	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
enhancer-promoter	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Uninfected	NULL
(	NULL
-	NULL
)	NULL
and	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
«	NULL
B-luc	NULL
concatemer	NULL
or	NULL
the	NULL
minimal	NULL
cona-luc	NULL
promoter	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Same	NULL
plasmids	NULL
transfected	NULL
into	NULL
uninfected	NULL
cells	NULL
stimulated	NULL
or	NULL
not	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
wild-type	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
enhancer-promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
MAD3	NULL
)	NULL
or	NULL
with	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
MAD3	NULL
AB	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
uninfected	NULL
(	NULL
-	NULL
)	NULL
or	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
cells	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
same	NULL
MAD3	NULL
reporter	NULL
genes	NULL
were	NULL
transfected	NULL
into	NULL
uninfected	NULL
cells	NULL
treated	NULL
or	NULL
not	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
B-Gal	NULL
activity	NULL
of	NULL
a	NULL
TK-B-Gal	NULL
plasmid	NULL
.	NULL

The	NULL
relative	NULL
fold	NULL
induction	NULL
by	NULL
HIV	NULL
or	NULL
LPS	NULL
is	NULL
indicated	NULL
over	NULL
each	NULL
bar	NULL
.	NULL

This	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
at	NULL
least	NULL
three	NULL
additional	NULL
experiments	NULL
.	NULL

quencing	NULL
of	NULL
the	NULL
promoter	NULL
identified	NULL
the	NULL
two	NULL
already	NULL
described	NULL
kB	NULL
sequences	NULL
(	NULL
B1	NULL
and	NULL
and	NULL
an	NULL
additional	NULL
one	NULL
(	NULL
B3	NULL
)	NULL
which	NULL
overlaps	NULL
a	NULL
putative	NULL
HIP1/E2F	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
each	NULL
of	NULL
these	NULL
four	NULL
motifs	NULL
(	NULL
«	NULL
Bl	NULL
,	NULL
B2	NULL
,	NULL
«	NULL
B3	NULL
,	NULL
and	NULL
HIP1/E2F	NULL
)	NULL
was	NULL
analyzed	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
labeled	NULL
oligonucleotides	NULL
of	NULL
each	NULL
of	NULL
these	NULL
sequences	NULL
.	NULL

Results	NULL
from	NULL
these	NULL
experiments	NULL
indicate	NULL
that	NULL
the	NULL
three	NULL
kB	NULL
motifs	NULL
but	NULL
not	NULL
HIP1/E2F	NULL
bind	NULL
a	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
induced	NULL
by	NULL
LPS	NULL
or	NULL
HIV	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

This	NULL
DNA-binding	NULL
activity	NULL
was	NULL
identified	NULL
as	NULL
NF-kB	NULL
,	NULL
the	NULL
kB3	NULL
motif	NULL
being	NULL
the	NULL
one	NULL
that	NULL
conferred	NULL
the	NULL
highest	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
three	NULL
kB	NULL
motifs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Using	NULL
transfection	NULL
experiments	NULL
,	NULL
we	NULL
next	NULL
tested	NULL
which	NULL
of	NULL
the	NULL
four	NULL
cis-acting	NULL
motifs	NULL
in	NULL
the	NULL
p105	NULL
promoter	NULL
mediates	NULL
its	NULL
upregulation	NULL
by	NULL
stimuli	NULL
that	NULL
activate	NULL
NF-kB	NULL
in	NULL
uninfected	NULL
and	NULL
in	NULL
HIV-infected	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5B	NULL
for	NULL
constructs	NULL
)	NULL
.	NULL

Deletions	NULL
of	NULL
the	NULL
four	NULL
motifs	NULL
in	NULL
the	NULL
wild-type	NULL
p105	NULL
promoter	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
were	NULL
introduced	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
tested	NULL
in	NULL
transfection	NULL
experiments	NULL
.	NULL

In	NULL
uninfected	NULL
cells	NULL
,	NULL
the	NULL
wild-type	NULL
p105	NULL
and	NULL
the	NULL
A	NULL
«	NULL
B2	NULL
and	NULL
AHIP1	NULL
constructs	NULL
were	NULL
responsive	NULL
to	NULL
a	NULL
cotransfected	NULL
p65	NULL
expression	NULL
plasmid	NULL
,	NULL
while	NULL
the	NULL
A	NULL
«	NULL
B1	NULL
motif	NULL
and	NULL
,	NULL
to	NULL
a	NULL
higher	NULL
degree	NULL
,	NULL
the	NULL
AxB3	NULL
motif	NULL
were	NULL
less	NULL
respon-sive	NULL
,	NULL
suggesting	NULL
that	NULL
(	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
kB1	NULL
)	NULL
mediates	NULL
p65	NULL
transactivation	NULL
of	NULL
the	NULL
wild-type	NULL
p105	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Similar	NULL
A	NULL
uss	NULL
?	NULL

z	NULL
macroph	NULL
.	NULL

B	NULL
IP	NULL
with	NULL
o	NULL
p105/50	NULL
C	NULL
NI	NULL
HIV	NULL
NI	NULL
HIV	NULL
NL	NULL
___	NULL
HIV	NULL
.	NULL

usey	NULL
p105	NULL
-|	NULL
swe	NULL
ese	NULL
®	NULL
_	NULL
minutes	NULL
:	NULL
0	NULL
180	NULL
0	NULL
180	NULL
--	NULL
-	NULL
p105	NULL
-	NULL
-	NULL
-	NULL
NJ	NULL
PMAHIV	NULL
pos	NULL
-	NULL
_	NULL
``	NULL
ls	NULL
'	NULL
caron-	NULL
SRE	NULL
p50	NULL
-	NULL
|	NULL
tees	NULL
.	NULL

emit	NULL
1	NULL
2	NULL
3	NULL
Can	NULL
we	NULL
_~-	NULL
p50	NULL
-	NULL
one	NULL
waw	NULL
wert	NULL
1	NULL
2	NULL
3	NULL
4	NULL
E	NULL
.-	NULL
we	NULL
-	NULL
.	NULL

IKBq	NULL
=-	NULL
«	NULL
«	NULL
«	NULL
=	NULL
&	NULL
=	NULL
10	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Cellular	NULL
sublocalization	NULL
,	NULL
synthesis	NULL
and	NULL
processing	NULL
,	NULL
and	NULL
steady-state	NULL
RNA	NULL
levels	NULL
of	NULL
p105	NULL
and	NULL
p50	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cytosolic	NULL
proteins	NULL
from	NULL
U937	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
were	NULL
extracted	NULL
,	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
,	NULL
and	NULL
immu-noblotted	NULL
with	NULL
anti-p105/p50	NULL
antibodies	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
run	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

NI	NULL
,	NULL
noninfected	NULL
.	NULL

(	NULL
B	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
for	NULL
20	NULL
min	NULL
,	NULL
chased	NULL
with	NULL
unlabeled	NULL
methionine-containing	NULL
medium	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
,	NULL
lysed	NULL
,	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
anti-p105/p50	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
*°S	NULL
labeling	NULL
on	NULL
non-p105/p50-related	NULL
proteins	NULL
were	NULL
equal	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

(	NULL
C	NULL
)	NULL
RNA	NULL
from	NULL
U937	NULL
cells	NULL
was	NULL
extracted	NULL
,	NULL
electrophoresed	NULL
,	NULL
transferred	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
°°P-labeled	NULL
p105	NULL
cDNA	NULL
probe	NULL
and	NULL
subsequently	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
GAPDH	NULL
probe	NULL
.	NULL

PMA	NULL
stimulation	NULL
of	NULL
U937	NULL
cells	NULL
was	NULL
done	NULL
with	NULL
a	NULL
concentration	NULL
of	NULL
20	NULL
ng/ml	NULL
for	NULL
2	NULL
h.	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
A	NULL
-87	NULL
+72	NULL
kB1	NULL
+61	NULL
-7	NULL
SP1	NULL
__	NULL
[	NULL
*~	NULL
acacaeaccececatocaceccectaicacacaccectcrcocaacasceccaaccaccoccaaacecceadaccccaca	NULL
74	NULL
r	NULL
``	NULL
118	NULL
kB2	NULL
128	NULL
|	NULL
154	NULL
213	NULL
kB3	NULL
222	NULL
HIP1	NULL
CCGCCCCCGCTGCGTGCGCGCGTGTGTCCGTCTGTCTGTATGCTCTCTCGACGTCAG	NULL
camgtaa	NULL
_	NULL
2s	NULL
217	NULL
227	NULL
intr	NULL
on	NULL
(	NULL
-671	NULL
)	NULL
IxBa	NULL
AND	NULL
p105	NULL
REGULATION	NULL
IN	NULL
HIV-INFECTED	NULL
MACROPHAGES	NULL
1505	NULL
.	NULL

(	NULL
+508	NULL
)	NULL
Hin	NULL
lll	NULL
Hiri	NULL
Neol	NULL
p10s	NULL
I	NULL
1	NULL
m	NULL
kB2	NULL
kB3	NULL
HIP	NULL
T	NULL
[	NULL
ser	NULL
ya	NULL
CACI	NULL
1.2HN-lue	NULL
kB1	NULL
-	NULL
kB2	NULL
kB3	NULL
HIP	NULL
T	NULL
|	NULL
x.	NULL
ver	NULL
Lom-	NULL
uce	NULL
kB2	NULL
kB3	NULL
|	NULL
HIPT	NULL
x	NULL
a	NULL
luc	NULL
AxB2-1.2HN-luc	NULL
kB	NULL
kB3	NULL
1	NULL
Tue	NULL
AHIP1-1.2HN-Lue	NULL
kB	NULL
1	NULL
kB	NULL
2	NULL
HIP1	NULL
I	NULL
(	NULL
g	NULL
Tue	NULL
xB3m-1	NULL
.2HN-I	NULL
ue	NULL
kB	NULL
1	NULL
kB	NULL
2	NULL
3m	NULL
HIP	NULL
1m	NULL
kB1	NULL
KB2	NULL
kBS	NULL
HIP	NULL
1	NULL
m-1.2HN-lue	NULL
FIG	NULL
.	NULL

5.	NULL
p105	NULL
enhancer-promoter	NULL
sequence	NULL
and	NULL
p105-luciferase	NULL
constructs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
p105	NULL
enhancer-promoter	NULL
(	NULL
modified	NULL
from	NULL
reference	NULL
73	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
transcription	NULL
initiation	NULL
sites	NULL
.	NULL

Boxes	NULL
indicate	NULL
specific	NULL
DNA	NULL
motifs	NULL
.	NULL

Numbering	NULL
of	NULL
nucleotides	NULL
is	NULL
from	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
p105-luciferase	NULL
constructs	NULL
.	NULL

Deletions	NULL
(	NULL
X	NULL
)	NULL
or	NULL
mutations	NULL
(	NULL
open	NULL
ovals	NULL
)	NULL
were	NULL
made	NULL
by	NULL
using	NULL
oligonucleotides	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
based	NULL
on	NULL
sequences	NULL
in	NULL
panel	NULL
A.	NULL
results	NULL
were	NULL
observedin	NULL
uninfected	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
and	NULL
PMA	NULL
:	NULL
<	NULL
kB3	NULL
but	NULL
not	NULL
the	NULL
other	NULL
motifs	NULL
mediates	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
of	NULL
a	NULL
wild-type	NULL
p105-luciferase	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

We	NULL
next	NULL
tested	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
deleted	NULL
plO5-luciferase	NULL
constructs	NULL
in	NULL
HIV-infected	NULL
and	NULL
uninfected	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
the	NULL
<	NULL
B3	NULL
motif	NULL
but	NULL
not	NULL
the	NULL
other	NULL
DNA-binding	NULL
motifs	NULL
also	NULL
mediates	NULL
p105	NULL
transactivation	NULL
by	NULL
HIV	NULL
.	NULL

DISCUSSION	NULL
Human	NULL
monocytes	NULL
and	NULL
macrophages	NULL
are	NULL
a	NULL
main	NULL
reservoir	NULL
of	NULL
persistent	NULL
HIV	NULL
replication	NULL
in	NULL
infected	NULL
individuals	NULL
(	NULL
20	NULL
,	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
mechanisms	NULL
regulating	NULL
viral	NULL
persistence	NULL
in	NULL
these	NULL
host	NULL
cells	NULL
still	NULL
remain	NULL
elusive	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
important	NULL
participant	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Whether	NULL
it	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
sustaining	NULL
viral	NULL
replication	NULL
through	NULL
interactions	NULL
with	NULL
regulatory	NULL
viral	NULL
proteins	NULL
such	NULL
as	NULL
Tat	NULL
is	NULL
not	NULL
known	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
persistent	NULL
HIV	NULL
infection	NULL
of	NULL
monocytic	NULL
cells	NULL
results	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
1	NULL
,	NULL
55	NULL
,	NULL
60	NULL
)	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
this	NULL
unique	NULL
virus-host	NULL
cell	NULL
transcription	NULL
factor	NULL
interaction	NULL
is	NULL
important	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
viral	NULL
persistence	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
interrupt	NULL
this	NULL
interaction	NULL
that	NULL
could	NULL
potentially	NULL
lead	NULL
to	NULL
decreased	NULL
viral	NULL
replication	NULL
,	NULL
it	NULL
is	NULL
mandatory	NULL
to	NULL
understand	NULL
(	NULL
i	NULL
)	NULL
how	NULL
NF-B	NULL
is	NULL
regulated	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
how	NULL
HIV	NULL
infection	NULL
influences	NULL
NF-kB	NULL
regulation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
1506	NULL
McELHINNY	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

``	NULL
°	NULL
``	NULL
1	NULL
D	NULL
preCMV	NULL
039-	NULL
40000	NULL
~	NULL
A	NULL
-J	NULL
g	NULL
20000	NULL
«	NULL
L-3	NULL
0	NULL
$	NULL
b	NULL
C	NULL
BSS	NULL
.	NULL

r-mume	NULL
@	NULL
1.2HN	NULL
A	NULL
kB1	NULL
A	NULL
kB2	NULL
A	NULL
HIP1	NULL
kB3m	NULL
HiPim	NULL
no	NULL
NS	NULL
«	NULL
~	NULL
INF	NULL
<	NULL
:	NULL
Sus	NULL
\	NULL
$	NULL
N	NULL
s	NULL
§	NULL
8	NULL
§	NULL
N	NULL
N	NULL
N	NULL
3	NULL
-|	NULL
-	NULL
R	NULL
S	NULL
s	NULL
N	NULL
3	NULL
NO	NULL
No	NULL
N	NULL
N	NULL
r	NULL
N	NULL
N	NULL
N	NULL
|N	NULL
N	NULL
$	NULL
N	NULL
TN	NULL
|D	NULL
N	NULL
S	NULL
Y	NULL
IN	NULL
|R	NULL
N	NULL
Re	NULL
N	NULL
ig	NULL
[	NULL
N	NULL
4	NULL
N	NULL
8	NULL
N	NULL
o	NULL
4	NULL
n	NULL
‘	NULL
|	NULL
%	NULL
\	NULL
8	NULL
sooco	NULL
!	NULL

I	NULL
:	NULL
C	NULL
33	NULL
8	NULL
isoco	NULL
!	NULL

C	NULL
E	NULL
5	NULL
3	NULL
*	NULL
1	NULL
3kluc.I	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Transfection	NULL
of	NULL
p105-luciferase	NULL
constructs	NULL
into	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Uninfected	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
with	NULL
p105-luciferase	NULL
constructs	NULL
and	NULL
a	NULL
control	NULL
prCMV	NULL
or	NULL
prCMV	NULL
p65	NULL
expression	NULL
vector	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Uninfected	NULL
U937	NULL
cells	NULL
transfected	NULL
with	NULL
p105	NULL
constructs	NULL
followed	NULL
by	NULL
no	NULL
stimulation	NULL
(	NULL
NS	NULL
)	NULL
,	NULL
TNF	NULL
(	NULL
40	NULL
pg/ml	NULL
)	NULL
,	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
18	NULL
b	NULL
.	NULL

(	NULL
C	NULL
)	NULL
U937	NULL
uninfected	NULL
(	NULL
UN	NULL
)	NULL
and	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
p105	NULL
constructs	NULL
and	NULL
a	NULL
3-kb	NULL
cona-luc	NULL
reporter	NULL
gene	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
B-Gal	NULL
activity	NULL
of	NULL
a	NULL
TK-Gal	NULL
plasmid	NULL
.	NULL

Representative	NULL
experiments	NULL
of	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
HIV	NULL
occurs	NULL
not	NULL
only	NULL
in	NULL
monocytic	NULL
cells	NULL
but	NULL
more	NULL
relevant	NULL
,	NULL
in	NULL
human	NULL
macrophages	NULL
,	NULL
and	NULL
that	NULL
two	NULL
different	NULL
IxB	NULL
molecules	NULL
,	NULL
IxBa	NULL
and	NULL
p105	NULL
,	NULL
are	NULL
selectively	NULL
modified	NULL
by	NULL
persistent	NULL
HIV	NULL
infection	NULL
.	NULL

This	NULL
would	NULL
appear	NULL
to	NULL
result	NULL
in	NULL
continuous	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
increased	NULL
transcription	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
promoters	NULL
,	NULL
such	NULL
as	NULL
p105	NULL
,	NULL
IxBa	NULL
,	NULL
and	NULL
HIV	NULL
promot-ers	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
NF-kB	NULL
complex	NULL
translocated	NULL
into	NULL
the	NULL
nucleus	NULL
of	NULL
infected	NULL
monocytes	NULL
and	NULL
macrophages	NULL
is	NULL
a	NULL
bona	NULL
fide	NULL
p50/p65	NULL
complex	NULL
in	NULL
which	NULL
c-Rel	NULL
is	NULL
absent	NULL
.	NULL

Because	NULL
NF-kB	NULL
and	NULL
related	NULL
family	NULL
members	NULL
are	NULL
regulated	NULL
by	NULL
complex	NULL
interactions	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
IxB	NULL
molecules	NULL
,	NULL
we	NULL
first	NULL
investigated	NULL
those	NULL
IxBs	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
to	NULL
interact	NULL
with	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Candidate	NULL
IxB	NULL
molecules	NULL
potentially	NULL
implicated	NULL
in	NULL
regulating	NULL
p65	NULL
and	NULL
p50	NULL
in	NULL
monocytic	NULL
cells	NULL
include	NULL
IxBa	NULL
and	NULL
p105	NULL
or	NULL
p100	NULL
.	NULL

Results	NULL
from	NULL
our	NULL
studies	NULL
indicate	NULL
that	NULL
persistent	NULL
HIV	NULL
infection	NULL
is	NULL
an	NULL
example	NULL
of	NULL
a	NULL
chronic	NULL
stimulus	NULL
which	NULL
targets	NULL
at	NULL
least	NULL
two	NULL
different	NULL
IxBs	NULL
,	NULL
IxBa	NULL
and	NULL
p105	NULL
.	NULL

IxBo	NULL
undergoes	NULL
posttranslational	NULL
modifications	NULL
(	NULL
degrada-tion	NULL
with	NULL
or	NULL
without	NULL
phosphorylation	NULL
)	NULL
induced	NULL
by	NULL
signal	NULL
transduction	NULL
pathways	NULL
triggered	NULL
by	NULL
a	NULL
cellular	NULL
stimulus	NULL
such	NULL
as	NULL
TNF	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
PMA	NULL
.	NULL

Although	NULL
the	NULL
relevance	NULL
of	NULL
IxBa	NULL
phosphorylation	NULL
as	NULL
a	NULL
requisite	NULL
for	NULL
subsequent	NULL
protein	NULL
degradation	NULL
remains	NULL
to	NULL
be	NULL
shown	NULL
,	NULL
all	NULL
of	NULL
the	NULL
punctual	NULL
stimuli	NULL
mentioned	NULL
above	NULL
have	NULL
been	NULL
unequivocally	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
IxBa	NULL
degradation	NULL
con-comitantly	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
53	NULL
,	NULL
70	NULL
,	NULL
71	NULL
)	NULL
.	NULL

In	NULL
the	NULL
model	NULL
of	NULL
persistent	NULL
HIV	NULL
infection	NULL
in	NULL
which	NULL
continuous	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
is	NULL
present	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
IxBa	NULL
levels	NULL
are	NULL
persistently	NULL
decreased	NULL
within	NULL
infected	NULL
monocytic	NULL
cells	NULL
and	NULL
macrophages	NULL
,	NULL
suggesting	NULL
that	NULL
IxBa	NULL
is	NULL
a	NULL
target	NULL
of	NULL
HIV-dependent	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
its	NULL
posttranslational	NULL
modification	NULL
(	NULL
s	NULL
)	NULL
.	NULL

At	NULL
this	NULL
point	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
HIV	NULL
infection	NULL
results	NULL
in	NULL
IxBa	NULL
phosphorylation	NULL
rendering	NULL
the	NULL
molecule	NULL
susceptible	NULL
to	NULL
subsequent	NULL
degradation	NULL
or	NULL
whether	NULL
proteolysis	NULL
occurs	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
specific	NULL
phosphorylation	NULL
.	NULL

Recently	NULL
,	NULL
persistent	NULL
expression	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
fax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
IxBa	NULL
degradation	NULL
(	NULL
37	NULL
,	NULL
69	NULL
)	NULL
preceded	NULL
by	NULL
its	NULL
phosphorylation	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Our	NULL
preliminary	NULL
data	NULL
derived	NULL
from	NULL
immunoprecipitation	NULL
experiments	NULL
of	NULL
°°P	NULL
;	NULL
and	NULL
[	NULL
°°S	NULL
]	NULL
methionine-labeled	NULL
cells	NULL
indicate	NULL
that	NULL
IxBa	NULL
is	NULL
a	NULL
phospho-protein	NULL
in	NULL
the	NULL
resting	NULL
state	NULL
and	NULL
that	NULL
an	NULL
additional	NULL
,	NULL
more	NULL
slowly	NULL
migrating	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
is	NULL
present	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Confirming	NULL
these	NULL
results	NULL
would	NULL
imply	NULL
that	NULL
models	NULL
of	NULL
chronic	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
such	NULL
as	NULL
the	NULL
one	NULL
presented	NULL
here	NULL
may	NULL
facilitate	NULL
the	NULL
study	NULL
of	NULL
the	NULL
phosphorylation	NULL
characteristics	NULL
of	NULL
IxBa	NULL
and	NULL
its	NULL
regulation	NULL
by	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

If	NULL
phosphorylation	NULL
and/or	NULL
other	NULL
posttranslational	NULL
modifications	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
predisposing	NULL
IxBa	NULL
to	NULL
subsequent	NULL
degradation	NULL
,	NULL
our	NULL
data	NULL
would	NULL
imply	NULL
that	NULL
at	NULL
least	NULL
a	NULL
proteolytic	NULL
mechanism	NULL
is	NULL
activated	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Whether	NULL
a	NULL
cellular	NULL
protease	NULL
is	NULL
upregulated	NULL
by	NULL
HIV	NULL
infection	NULL
such	NULL
as	NULL
via	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
or	NULL
whether	NULL
the	NULL
HIV	NULL
protease	NULL
itself	NULL
(	NULL
53	NULL
,	NULL
59	NULL
)	NULL
regulates	NULL
IxBa	NULL
degradation	NULL
remains	NULL
unknown	NULL
.	NULL

Alternatively	NULL
,	NULL
continuous	NULL
IxBa	NULL
phosphorylation	NULL
by	NULL
HIV-dependent	NULL
signal	NULL
transduction	NULL
pathways	NULL
would	NULL
suffice	NULL
to	NULL
render	NULL
the	NULL
molecule	NULL
susceptible	NULL
to	NULL
normally	NULL
functional	NULL
cell	NULL
proteolytic	NULL
pathways	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
undergoes	NULL
some	NULL
degree	NULL
of	NULL
proteolysis	NULL
in	NULL
resting	NULL
nonactivated	NULL
cells	NULL
as	NULL
shown	NULL
in	NULL
other	NULL
studies	NULL
(	NULL
57	NULL
)	NULL
suggests	NULL
that	NULL
proteolytic	NULL
pathways	NULL
are	NULL
functional	NULL
.	NULL

The	NULL
notion	NULL
that	NULL
increased	NULL
IxBa	NULL
proteolysis	NULL
in	NULL
HIV-infected	NULL
cells	NULL
occurs	NULL
in	NULL
the	NULL
face	NULL
of	NULL
a	NULL
compensatory	NULL
but	NULL
apparently	NULL
insufficient	NULL
enhanced	NULL
protein	NULL
synthesis	NULL
is	NULL
novel	NULL
and	NULL
helps	NULL
to	NULL
explain	NULL
that	NULL
persistently	NULL
decreased	NULL
IxBa	NULL
levels	NULL
result	NULL
in	NULL
continuous	NULL
NF-kB	NULL
translocation	NULL
.	NULL

The	NULL
transcriptional	NULL
regulation	NULL
of	NULL
IxBa	NULL
by	NULL
NF-	NULL
«	NULL
kB	NULL
has	NULL
been	NULL
clearly	NULL
demonstrated	NULL
and	NULL
supports	NULL
that	NULL
concept	NULL
of	NULL
autoregu-	NULL
IxBa	NULL
AND	NULL
p105	NULL
REGULATION	NULL
IN	NULL
HIV-INFECTED	NULL
MACROPHAGES	NULL
1507	NULL
lation	NULL
between	NULL
NF-kB	NULL
and	NULL
IxBa	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
40	NULL
,	NULL
57	NULL
,	NULL
65	NULL
,	NULL
70	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Transient	NULL
stimuli	NULL
that	NULL
result	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
by	NULL
inducing	NULL
degradation	NULL
of	NULL
IxBa	NULL
also	NULL
increase	NULL
its	NULL
transcription	NULL
.	NULL

This	NULL
mechanism	NULL
compensates	NULL
the	NULL
utilization	NULL
(	NULL
degradation	NULL
)	NULL
of	NULL
IxBa	NULL
and	NULL
interrupts	NULL
continuous	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
:	NULL
newly	NULL
synthesized	NULL
IxBa	NULL
will	NULL
anchor	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
avoiding	NULL
its	NULL
subsequent	NULL
nuclear	NULL
translocation	NULL
unless	NULL
new	NULL
cell	NULL
stimulation	NULL
occurs	NULL
.	NULL

In	NULL
our	NULL
model	NULL
,	NULL
in	NULL
which	NULL
HIV	NULL
behaves	NULL
as	NULL
a	NULL
persistent	NULL
stimulus	NULL
,	NULL
this	NULL
autoregulatory	NULL
shutoff	NULL
mechanism	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
IxBa	NULL
is	NULL
only	NULL
partially	NULL
functional	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
continuous	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
not	NULL
unexpected	NULL
that	NULL
increased	NULL
levels	NULL
of	NULL
IxBa	NULL
RNA	NULL
and	NULL
,	NULL
more	NULL
importantly	NULL
,	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
IxBa	NULL
enhancer-promoter	NULL
via	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
are	NULL
present	NULL
in	NULL
HIV-infected	NULL
cells	NULL
in	NULL
an	NULL
attempt	NULL
to	NULL
compensate	NULL
for	NULL
the	NULL
unbalanced	NULL
IxBa	NULL
degradation	NULL
.	NULL

Other	NULL
IxB	NULL
molecules	NULL
have	NULL
been	NULL
found	NULL
to	NULL
be	NULL
functional	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
origin	NULL
.	NULL

Because	NULL
p50/p65	NULL
is	NULL
the	NULL
main	NULL
complex	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
cells	NULL
persistently	NULL
infected	NULL
with	NULL
HIV	NULL
,	NULL
IxB	NULL
molecules	NULL
such	NULL
as	NULL
p105	NULL
and	NULL
p100	NULL
could	NULL
also	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
HIV	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
for	NULL
any	NULL
of	NULL
these	NULL
molecules	NULL
to	NULL
generate	NULL
p50-	NULL
or	NULL
pS2-containing	NULL
p65	NULL
heterodimers	NULL
,	NULL
proteolytical	NULL
cleavage	NULL
of	NULL
the	NULL
precursor	NULL
needs	NULL
to	NULL
occur	NULL
(	NULL
9	NULL
,	NULL
21	NULL
,	NULL
38	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Although	NULL
few	NULL
data	NULL
as	NULL
to	NULL
what	NULL
physiological	NULL
stimuli	NULL
result	NULL
in	NULL
this	NULL
cleavage	NULL
are	NULL
available	NULL
,	NULL
an	NULL
underlying	NULL
functional	NULL
processing	NULL
is	NULL
continuously	NULL
present	NULL
in	NULL
any	NULL
resting	NULL
cell	NULL
to	NULL
explain	NULL
the	NULL
continuous	NULL
formation	NULL
of	NULL
p50	NULL
or	NULL
p52	NULL
.	NULL

Although	NULL
some	NULL
reports	NULL
indicate	NULL
that	NULL
processing	NULL
of	NULL
p105	NULL
or	NULL
p100	NULL
can	NULL
be	NULL
increased	NULL
by	NULL
different	NULL
stimuli	NULL
(	NULL
TNF	NULL
and	NULL
LPS	NULL
)	NULL
to	NULL
result	NULL
in	NULL
p50	NULL
(	NULL
46	NULL
,	NULL
75	NULL
)	NULL
,	NULL
this	NULL
has	NULL
not	NULL
been	NULL
confirmed	NULL
by	NULL
others	NULL
(	NULL
71	NULL
)	NULL
,	NULL
leaving	NULL
the	NULL
issue	NULL
of	NULL
p105	NULL
and	NULL
p100	NULL
regulation	NULL
open	NULL
to	NULL
further	NULL
studies	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
a	NULL
chronic	NULL
stimulus	NULL
such	NULL
as	NULL
HIV	NULL
increases	NULL
the	NULL
processing	NULL
of	NULL
p105	NULL
implies	NULL
that	NULL
p50/p65	NULL
heterodimers	NULL
aside	NULL
from	NULL
p50	NULL
homodimers	NULL
can	NULL
be	NULL
generated	NULL
by	NULL
this	NULL
mechanism	NULL
independently	NULL
targeting	NULL
IxBa	NULL
.	NULL

Because	NULL
in	NULL
our	NULL
model	NULL
IxBa	NULL
levels	NULL
are	NULL
decreased	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
p50/p65	NULL
heterodimers	NULL
generated	NULL
from	NULL
p105	NULL
processing	NULL
would	NULL
be	NULL
anchored	NULL
by	NULL
IxBa	NULL
,	NULL
therefore	NULL
freeing	NULL
them	NULL
for	NULL
nuclear	NULL
translocation	NULL
in	NULL
the	NULL
infected	NULL
cells	NULL
.	NULL

Preliminary	NULL
data	NULL
indicate	NULL
that	NULL
steady-state	NULL
levels	NULL
of	NULL
p100	NULL
and	NULL
p52	NULL
are	NULL
also	NULL
increased	NULL
in	NULL
HIV-infected	NULL
compared	NULL
with	NULL
uninfected	NULL
cells	NULL
,	NULL
although	NULL
it	NULL
is	NULL
unknown	NULL
if	NULL
the	NULL
processing	NULL
of	NULL
p100	NULL
as	NULL
that	NULL
described	NULL
here	NULL
for	NULL
p105	NULL
is	NULL
also	NULL
increased	NULL
.	NULL

Importantly	NULL
,	NULL
if	NULL
functional	NULL
differences	NULL
in	NULL
IxB	NULL
activity	NULL
exist	NULL
between	NULL
p105	NULL
and	NULL
p100	NULL
,	NULL
as	NULL
already	NULL
shown	NULL
for	NULL
differences	NULL
in	NULL
the	NULL
transactivational	NULL
activity	NULL
of	NULL
their	NULL
proteolytic	NULL
products	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
respectively	NULL
(	NULL
63	NULL
)	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
perform	NULL
detailed	NULL
analysis	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
precursors	NULL
by	NULL
chronic	NULL
stimuli	NULL
such	NULL
as	NULL
HIV	NULL
.	NULL

As	NULL
in	NULL
the	NULL
case	NULL
of	NULL
IxBa	NULL
,	NULL
it	NULL
remains	NULL
unknown	NULL
by	NULL
which	NULL
mechanisms	NULL
persistent	NULL
HIV	NULL
infection	NULL
increases	NULL
the	NULL
normal	NULL
ongoing	NULL
processing	NULL
of	NULL
p105	NULL
.	NULL

Although	NULL
the	NULL
HIV	NULL
protease	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
cleave	NULL
p105	NULL
in	NULL
a	NULL
model	NULL
of	NULL
acute	NULL
HIV	NULL
infection	NULL
in	NULL
T-lymphoblastoid	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
activation	NULL
of	NULL
already	NULL
functional	NULL
proteolytic	NULL
pathways	NULL
is	NULL
upregulated	NULL
by	NULL
HIV-dependent	NULL
mechanisms	NULL
.	NULL

Lastly	NULL
,	NULL
our	NULL
studies	NULL
provide	NULL
additional	NULL
information	NULL
on	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
p105	NULL
enhancer-promoter	NULL
by	NULL
stimuli	NULL
that	NULL
activate	NULL
NF-kB	NULL
,	NULL
especially	NULL
HIV	NULL
.	NULL

Although	NULL
our	NULL
group	NULL
has	NULL
previously	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HIV	NULL
upregulate	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
enhancer-promoter	NULL
of	NULL
this	NULL
gene	NULL
(	NULL
55	NULL
)	NULL
,	NULL
we	NULL
have	NULL
been	NULL
interested	NULL
in	NULL
further	NULL
characterizing	NULL
whether	NULL
HIV	NULL
requires	NULL
DNA-binding	NULL
motifs	NULL
different	NULL
from	NULL
those	NULL
binding	NULL
NF-xB	NULL
.	NULL

To	NULL
achieve	NULL
this	NULL
,	NULL
we	NULL
performed	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B-binding	NULL
motifs	NULL
as	NULL
well	NULL
as	NULL
an	NULL
additional	NULL
one	NULL
,	NULL
HIP1/E2F	NULL
(	NULL
45	NULL
)	NULL
.	NULL

By	NULL
sequencing	NULL
the	NULL
mutated	NULL
constructs	NULL
,	NULL
an	NULL
extra	NULL
NF-kB	NULL
motif	NULL
(	NULL
B3	NULL
)	NULL
overlapping	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
HIP1/E2F	NULL
motif	NULL
was	NULL
noted	NULL
.	NULL

A	NULL
similar	NULL
sequence	NULL
was	NULL
docu-mented	NULL
,	NULL
although	NULL
not	NULL
mentioned	NULL
or	NULL
analyzed	NULL
,	NULL
in	NULL
a	NULL
second	NULL
1508	NULL
McELHINNY	NULL
ET	NULL
AL	NULL
.	NULL

report	NULL
describing	NULL
the	NULL
enhancer-promoter	NULL
of	NULL
p105	NULL
(	NULL
14	NULL
)	NULL
.	NULL

By	NULL
performing	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
transfection	NULL
experiments	NULL
addressing	NULL
the	NULL
role	NULL
of	NULL
each	NULL
of	NULL
the	NULL
three	NULL
kB	NULL
motifs	NULL
and	NULL
the	NULL
single	NULL
HIP1	NULL
motif	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
xkB3	NULL
motif	NULL
and	NULL
not	NULL
the	NULL
HIP1	NULL
motif	NULL
is	NULL
the	NULL
main	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
enhancer-promoter	NULL
of	NULL
the	NULL
p105	NULL
gene	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HIV	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
implying	NULL
that	NULL
its	NULL
upregulation	NULL
of	NULL
HIV	NULL
is	NULL
mainly	NULL
mediated	NULL
by	NULL
its	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
not	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
the	NULL
xB3	NULL
motif	NULL
confers	NULL
cell	NULL
specificity	NULL
.	NULL

Preliminary	NULL
studies	NULL
in	NULL
B-cell	NULL
lines	NULL
indicate	NULL
that	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
LMP-1	NULL
protein	NULL
and	NULL
LPS	NULL
,	NULL
both	NULL
of	NULL
which	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
p105	NULL
transcription	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
upregulate	NULL
the	NULL
p105	NULL
promoter	NULL
independently	NULL
from	NULL
the	NULL
xB3	NULL
motif	NULL
(	NULL
44a	NULL
)	NULL
.	NULL

Viruses	NULL
and	NULL
specific	NULL
viral	NULL
proteins	NULL
have	NULL
been	NULL
listed	NULL
among	NULL
the	NULL
different	NULL
stimuli	NULL
known	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
3	NULL
)	NULL
.	NULL

At	NULL
least	NULL
in	NULL
the	NULL
case	NULL
of	NULL
HIV	NULL
and	NULL
to	NULL
a	NULL
certain	NULL
degree	NULL
with	NULL
Epstein-Barr	NULL
virus	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
increased	NULL
activity	NULL
triggered	NULL
by	NULL
persistent	NULL
viral	NULL
infection	NULL
accompanies	NULL
upregulation	NULL
of	NULL
cellular	NULL
receptors	NULL
and	NULL
functions	NULL
which	NULL
may	NULL
in	NULL
part	NULL
be	NULL
NF-kB	NULL
dependent	NULL
,	NULL
suggesting	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
transcriptional	NULL
factor	NULL
.	NULL

Furthermore	NULL
,	NULL
persistent	NULL
HIV	NULL
infection	NULL
of	NULL
macrophages	NULL
provides	NULL
an	NULL
example	NULL
of	NULL
how	NULL
a	NULL
continuous	NULL
stimulus	NULL
such	NULL
as	NULL
HIV	NULL
can	NULL
modify	NULL
and	NULL
upregulate	NULL
cellular	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
NF-kB	NULL
activation	NULL
,	NULL
specifically	NULL
by	NULL
modulating	NULL
at	NULL
least	NULL
two	NULL
separate	NULL
and	NULL
independent	NULL
IxB	NULL
molecules	NULL
such	NULL
as	NULL
IxBa	NULL
and	NULL
p105	NULL
.	NULL

Advancing	NULL
in	NULL
our	NULL
understanding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulation	NULL
by	NULL
HIV	NULL
will	NULL
allow	NULL
determination	NULL
of	NULL
the	NULL
role	NULL
of	NULL
this	NULL
crucial	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV	NULL
persistence	NULL
in	NULL
human	NULL
macrophages	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
acknowledge	NULL
the	NULL
help	NULL
of	NULL
Evelyn	NULL
Torres	NULL
in	NULL
generating	NULL
the	NULL
glutathione	NULL
S-transferase-MAD3	NULL
fusion	NULL
protein	NULL
,	NULL
Véronique	NULL
Rolli	NULL
for	NULL
generating	NULL
the	NULL
p105	NULL
promoter	NULL
plasmids	NULL
containing	NULL
deletions	NULL
of	NULL
the	NULL
HIP1	NULL
motif	NULL
,	NULL
and	NULL
Doug	NULL
Hauschild	NULL
for	NULL
outstanding	NULL
secretarial	NULL
help	NULL
.	NULL

This	NULL
work	NULL
was	NULL
in	NULL
part	NULL
supported	NULL
by	NULL
the	NULL
American	NULL
Foundation	NULL
for	NULL
AIDS	NULL
Research	NULL
(	NULL
C.V.P	NULL
.	NULL

is	NULL
an	NULL
AMFAR	NULL
scholar	NULL
)	NULL
,	NULL
by	NULL
the	NULL
Mayo	NULL
Foun-dation	NULL
,	NULL
and	NULL
by	NULL
NIH	NULL
ROL	NULL
AI36076-01	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:709-712	NULL
.	NULL

2	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

I	NULL
«	NULL
B	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:63-80	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

5	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

6	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
of	NULL
NF-xB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

7	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-xB	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913	NULL
.	NULL

8	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Gatignol	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
and	NULL
K.	NULL
T.	NULL
Jeang	NULL
.	NULL

1990	NULL
.	NULL

Tar-independent	NULL
activation	NULL
of	NULL
the	NULL
LTR	NULL
:	NULL
evidence	NULL
that	NULL
tat	NULL
requires	NULL
specific	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Cell	NULL
62:757-767	NULL
.	NULL

9	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1991	NULL
.	NULL

Cytoplasmic	NULL
retention	NULL
,	NULL
DNA	NULL
binding	NULL
and	NULL
processing	NULL
of	NULL
the	NULL
NF-kB	NULL
p50	NULL
precursor	NULL
are	NULL
controlled	NULL
by	NULL
a	NULL
small	NULL
region	NULL
in	NULL
its	NULL
C-terminus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:4159-4167	NULL
.	NULL

10	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50/p105-NF-kB	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
xB	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695	NULL
.	NULL

11	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-kB	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
I	NULL
«	NULL
B-e.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
S.	NULL
Miyamoto	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
IxBa	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:28-32	NULL
.	NULL

Cogswell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Promoter	NULL
of	NULL
the	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p50/p105	NULL
gene	NULL
:	NULL
regulation	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
and	NULL
by	NULL
c-rel	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:2794-2804	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
R.	NULL
Donald	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysaccharide	NULL
induces	NULL
phosphorylation	NULL
of	NULL
MAD3	NULL
and	NULL
activation	NULL
of	NULL
c-rel	NULL
and	NULL
related	NULL
NF-kB	NULL
proteins	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:11803-11810	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
1991	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

5:2361-2368	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
D.	NULL
L.	NULL
Simmons	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Rel-associated	NULL
pp40	NULL
:	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Science	NULL
253:1268-1271	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Dobrazanski	NULL
,	NULL
P.	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1993	NULL
.	NULL

Both	NULL
N-	NULL
and	NULL
C-terminal	NULL
domains	NULL
of	NULL
ReIB	NULL
are	NULL
required	NULL
for	NULL
full	NULL
transactivation	NULL
:	NULL
role	NULL
of	NULL
the	NULL
N-terminal	NULL
leucine	NULL
zipper-like	NULL
motif	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1572-1582	NULL
.	NULL

Embretson	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Zupancic	NULL
,	NULL
J.	NULL
L.	NULL
Ribas	NULL
,	NULL
A.	NULL
Burke	NULL
,	NULL
P.	NULL
Racz	NULL
,	NULL
K.	NULL
Tenner-Racz	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Haase	NULL
.	NULL

1993	NULL
.	NULL

Massive	NULL
covert	NULL
infection	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
and	NULL
macrophages	NULL
by	NULL
HIV	NULL
during	NULL
the	NULL
incubation	NULL
period	NULL
of	NULL
AIDS	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
362:359-362	NULL
.	NULL

Fan	NULL
,	NULL
C.-M.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1991	NULL
.	NULL

Generation	NULL
of	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
processing	NULL
of	NULL
p105	NULL
through	NULL
an	NULL
ATP-dependent	NULL
pathway	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
354:395-398	NULL
.	NULL

Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Frankel	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
fat	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
life	NULL
cycle	NULL
indicates	NULL
a	NULL
primary	NULL
effect	NULL
on	NULL
transcriptional	NULL
elongation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:4045-4049	NULL
.	NULL

Fort	NULL
,	NULL
P.	NULL
1985	NULL
.	NULL

Various	NULL
rat	NULL
adult	NULL
tissues	NULL
express	NULL
only	NULL
one	NULL
major	NULL
mRNA	NULL
species	NULL
from	NULL
the	NULL
glyceraldehyde-3-phosphate-dehydrogenase	NULL
multigenic	NULL
family	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13:1431-1432	NULL
.	NULL

Frantz	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
C.	NULL
Nordby	NULL
,	NULL
G.	NULL
Bren	NULL
,	NULL
N.	NULL
Steffan	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
M.	NULL
J.	NULL
Tocci	NULL
,	NULL
S.	NULL
J.	NULL
O'Keefe	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
O'Neill	NULL
.	NULL

1994	NULL
.	NULL

Calcineurin	NULL
acts	NULL
in	NULL
synergy	NULL
with	NULL
PMA	NULL
to	NULL
inactivate	NULL
IxB/MAD3	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:861-870.	NULL
.	NULL

Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
F.	NULL
K.	NULL
Wu	NULL
,	NULL
R.	NULL
Misuyasu	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1987	NULL
.	NULL

Interactions	NULL
of	NULL
cellular	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

63761-3770	NULL
.	NULL

Gartner	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Markovits	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
M.	NULL
H.	NULL
Kaplan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
M.	NULL
Popovie	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
HTLV-II/LAV	NULL
infection	NULL
.	NULL

Science	NULL
233:215-219	NULL
.	NULL

Gendelman	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
J.	NULL
M.	NULL
Orenstein	NULL
,	NULL
L.	NULL
M.	NULL
Baca	NULL
,	NULL
B.	NULL
Weiser	NULL
,	NULL
H.	NULL
Burger	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Kalter	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
macrophage	NULL
in	NULL
the	NULL
persistence	NULL
and	NULL
pathogenesis	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

AIDS	NULL
3:475-495	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:678-682	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
339:70-73	NULL
.	NULL

Haskill	NULL
,	NULL
D.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Neriab	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxB-	NULL
«	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
A.	NULL
Kakizuka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1992	NULL
.	NULL

IxB-gamma	NULL
,	NULL
a	NULL
70	NULL
Kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-kB	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

Cell	NULL
68:1109-1120	NULL
.	NULL

Ip	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
R.	NULL
Kraut	NULL
,	NULL
M.	NULL
Levine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rushlow	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
dorsal	NULL
mor-phogen	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
long-range	NULL
repression	NULL
element	NULL
in	NULL
Drosophila	NULL
.	NULL

Cell	NULL
64:439-446	NULL
.	NULL

Jain	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
I.	NULL
Magrath	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
chemiluminescent	NULL
assay	NULL
for	NULL
quantitation	NULL
of	NULL
B-galactosidase	NULL
in	NULL
the	NULL
femtogram	NULL
range	NULL
:	NULL
application	NULL
to	NULL
quantitation	NULL
of	NULL
B-galactosidase	NULL
in	NULL
lac-Z	NULL
transfected	NULL
cells	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

199:119-124	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1993	NULL
.	NULL

Tat	NULL
and	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5:461-468	NULL
.	NULL

Kamine	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Subramanian	NULL
,	NULL
and	NULL
G.	NULL
Chinnadurai	NULL
.	NULL

1991	NULL
.	NULL

Sp/-dependent	NULL
activation	NULL
of	NULL
a	NULL
synthetic	NULL
promoter	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
tat	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:8510-8514	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
fax-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6443-6451	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Koenig	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
J.	NULL
M.	NULL
Orenstein	NULL
,	NULL
M.	NULL
C.	NULL
DalCanto	NULL
,	NULL
G.	NULL
H.	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

Pezeshkpour	NULL
,	NULL
M.	NULL
Yungblot	NULL
,	NULL
A.	NULL
Aksamit	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1986	NULL
.	NULL

Detection	NULL
of	NULL
AIDS	NULL
virus	NULL
in	NULL
macrophages	NULL
in	NULL
brain	NULL
tissue	NULL
from	NULL
AIDS	NULL
patients	NULL
with	NULL
encephalopathy	NULL
.	NULL

Science	NULL
233:1089-1093	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
R.	NULL
Schmidt-Ullrich	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
1993	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
rel/NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5043-5049	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/rel	NULL
transcription	NULL
factor	NULL
and	NULL
IxB	NULL
inhibitor	NULL
system	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5:477-487	NULL
.	NULL

Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
S.	NULL
Ghosb	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
,	NULL
p105	NULL
,	NULL
contains	NULL
an	NULL
internal	NULL
I	NULL
«	NULL
B-like	NULL
inhibitor	NULL
that	NULL
preferentially	NULL
inhibits	NULL
p50	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3003-3009	NULL
.	NULL

Marciniak	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1991	NULL
.	NULL

Tet	NULL
protein	NULL
promotes	NULL
formation	NULL
of	NULL
more	NULL
processive	NULL
elongation	NULL
complexes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:4189-4196	NULL
.	NULL

44a.Herrero	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
P.	NULL
Mathew	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Paya	NULL
.	NULL

LMP-1	NULL
activates	NULL
NF-kB	NULL
by	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57.	NULL
targeting	NULL
the	NULL
inhibitory	NULL
molecule	NULL
IxBa	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
Means	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farnham	NULL
.	NULL

1990	NULL
.	NULL

Transcription	NULL
initiation	NULL
from	NULL
the	NULL
dihydrofolate	NULL
reductase	NULL
promoter	NULL
is	NULL
positioned	NULL
by	NULL
HIP-1	NULL
binding	NULL
at	NULL
the	NULL
initiation	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:653-661	NULL
.	NULL

Mellits	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1993	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
MAD3	NULL
(	NULL
IxBa	NULL
)	NULL
and	NULL
enhanced	NULL
processing	NULL
of	NULL
the	NULL
NF-kB	NULL
precursor	NULL
p105	NULL
are	NULL
obligatory	NULL
steps	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5059-5066	NULL
.	NULL

Merrill	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1991	NULL
.	NULL

HIV-1	NULL
,	NULL
macrophages	NULL
,	NULL
glial	NULL
cells	NULL
,	NULL
and	NULL
cytokines	NULL
in	NULL
AIDS	NULL
nervous	NULL
system	NULL
disease	NULL
.	NULL

FASEB	NULL
.	NULL

J	NULL
.	NULL

5:2391-2397	NULL
.	NULL

Mikovits	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Raziuddin	NULL
,	NULL
M.	NULL
Gonda	NULL
,	NULL
M.	NULL
Ruta	NULL
,	NULL
N.	NULL
C.	NULL
Lohrey	NULL
,	NULL
H.	NULL
F.	NULL
King	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
.	NULL

1990	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
human	NULL
immune	NULL
deficiency	NULL
virus	NULL
replication	NULL
in	NULL
monocytes	NULL
.	NULL

Distinctions	NULL
between	NULL
restricted	NULL
and	NULL
latent	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:1705-1720	NULL
.	NULL

Molina	NULL
,	NULL
J.-M.	NULL
,	NULL
R.	NULL
Schindler	NULL
,	NULL
R.	NULL
Ferriani	NULL
,	NULL
M.	NULL
Sakaguchi	NULL
,	NULL
E.	NULL
Vannier	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Groopman	NULL
.	NULL

1990	NULL
.	NULL

Production	NULL
of	NULL
cytokines	NULL
by	NULL
peripheral	NULL
blood	NULL
monocytes/macrophages	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

161:888-893	NULL
.	NULL

Munis	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
D.	NULL
D.	NULL
Richman	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Kornbluth	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus-1	NULL
infection	NULL
of	NULL
macrophages	NULL
in	NULL
vitro	NULL
neither	NULL
induces	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
/cachectin	NULL
gene	NULL
expression	NULL
nor	NULL
alters	NULL
TNF/cachectin	NULL
induction	NULL
by	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:591-596	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
ref	NULL
related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
J.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
78:773-785	NULL
.	NULL

Pantaleo	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
Graziosi	NULL
,	NULL
J.	NULL
F.	NULL
Demarest	NULL
,	NULL
L.	NULL
Mutini	NULL
,	NULL
M.	NULL
Montroni	NULL
,	NULL
C.	NULL
H.	NULL
Fox	NULL
,	NULL
J.	NULL
M.	NULL
Orenstein	NULL
,	NULL
D.	NULL
P.	NULL
Kotler	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

HIV	NULL
infection	NULL
is	NULL
active	NULL
and	NULL
progressive	NULL
in	NULL
lymphoid	NULL
tissue	NULL
during	NULL
the	NULL
clinically	NULL
latent	NULL
stage	NULL
of	NULL
disease	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
362:355-358	NULL
.	NULL

Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B-dependent	NULL
induction	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
gene	NULL
promoter	NULL
underlies	NULL
self-perpetuation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7826-7830	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
N.	NULL
L.	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3551-3558	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Ernst	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vivo	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IxBa	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4685-4695	NULL
.	NULL

IxBa	NULL
AND	NULL
p105	NULL
REGULATION	NULL
IN	NULL
HIV-INFECTED	NULL
MACROPHAGES	NULL
58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

1509	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253	NULL
.	NULL

Riviere	NULL
,	NULL
Y.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1991	NULL
.	NULL

Processing	NULL
of	NULL
the	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
HIV-1	NULL
protease	NULL
during	NULL
acute	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:625-628	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
D'Addario	NULL
,	NULL
F.	NULL
Boulerice	NULL
,	NULL
S.	NULL
Caplan	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
and	NULL
NF-	NULL
«	NULL
B-like	NULL
activities	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
infection	NULL
of	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:751-763	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J.	NULL
F.	NULL
Klement	NULL
,	NULL
T.	NULL
A.	NULL
Coleman	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

I-Rel	NULL
:	NULL
a	NULL
novel	NULL
re/-related	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:745-760	NULL
.	NULL

Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
p100	NULL
(	NULL
Lyt-10	NULL
)	NULL
is	NULL
a	NULL
component	NULL
of	NULL
H2TF1	NULL
and	NULL
can	NULL
function	NULL
as	NULL
an	NULL
I	NULL
«	NULL
B-like	NULL
molecule	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6089-6101	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p63	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

Schwartz	NULL
,	NULL
O.	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
L.	NULL
Montagnier	NULL
,	NULL
and	NULL
U.	NULL
Hazan	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
micro-transfection	NULL
method	NULL
using	NULL
the	NULL
luciferasc-encoding	NULL
reporter	NULL
gene	NULL
for	NULL
the	NULL
assay	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
LTR	NULL
promoter	NULL
activity	NULL
.	NULL

Gene	NULL
88	NULL
:	NULL
197-205	NULL
.	NULL

Scott	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulates	NULL
IxB	NULL
by	NULL
two	NULL
distinct	NULL
mechanisms	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1266-1276	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46:705-716	NULL
.	NULL

Simek	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1988	NULL
.	NULL

Detection	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
chicken	NULL
c-ref	NULL
protooncogene	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

2:103-119	NULL
.	NULL

Southgate	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
HIV-1	NULL
fat	NULL
protein	NULL
activates	NULL
transcription	NULL
from	NULL
an	NULL
upstream	NULL
DNA-binding	NULL
site	NULL
:	NULL
implications	NULL
for	NULL
tet	NULL
func-tion	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:2496-2507	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
fax	NULL
activation	NULL
of	NULL
NF-xB/Re	NULL
!	NULL

involves	NULL
phosphorylation	NULL
to	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
c-re/	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transactivator	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1346-1350	NULL
.	NULL

Taylor	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
R.	NULL
Pomerantz	NULL
,	NULL
O.	NULL
Bagasra	NULL
,	NULL
M.	NULL
Chowdhury	NULL
,	NULL
J.	NULL
Rappaport	NULL
,	NULL
K.	NULL
Khalili	NULL
,	NULL
and	NULL
S.	NULL
Amini	NULL
.	NULL

1992	NULL
.	NULL

Tar-independent	NULL
transactivation	NULL
by	NULL
fat	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
CNS	NULL
:	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
HIV-1	NULL
gene	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3395-3403	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
N.	NULL
Israél	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.-G.	NULL
Mattei	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kB	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:195-203	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

Purified	NULL
human	NULL
IxB	NULL
can	NULL
rapidly	NULL
dissociate	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Cell	NULL
61:255-265	NULL
.	NULL

Zheng	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
C.	NULL
Brown	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Taffet	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysaccharide	NULL
stimulates	NULL
both	NULL
nuclear	NULL
localization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
50	NULL
kDa	NULL
subunit	NULL
and	NULL
loss	NULL
of	NULL
the	NULL
105	NULL
kDa	NULL
precursor	NULL
in	NULL
RAW264	NULL
macrophage-like	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
17233-17239	NULL
.	NULL

